Name
Peptides
Accession Number
DBCAT000052
Description

Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.

Drugs
DrugDrug Description
.gamma.-brain natriuretic peptideNot Annotated
9-(N-methyl-L-isoleucine)-cyclosporin A9-(N-methyl-L-isoleucine)-cyclosporin A (NIM811) has been used in trials studying the treatment of Chronic Hepatitis C Genotype-1 Relapse.
99mTc-HYNIC (Tyr3)-octreotideNot Annotated
AbaloparatideA parathyroid hormone-related protein (PTHrP) analog used for the treatment of osteoporosis in patients with a high risk of fracture.
AbarelixFor palliative treatment of advanced prostate cancer.
AbciximabA monoclonal anti-glycoprotein IIb/IIIa receptor antibody used to prevent thrombosis during percutaneous coronary intervention.
ABT-510Investigated for use/treatment in lymphoma (unspecified), melanoma, and solid tumors.
Acetyl hexapeptide-3Argireline has been used in trials studying the treatment of wrinkles.
acetylleucyl-leucyl-norleucinalNot Available
AclerastideAclerastide has been investigated for the treatment of Diabetic Foot, Diabetic Foot Ulcers, and Foot Ulcer, Diabetic.
ACV tripeptideNot Available
AcylineAcyline has been investigated for the prevention and treatment of Hypogonadism and Contraception.
AdrenomedullinAdrenomedullin is under investigation in clinical trial NCT06072118 (Adrenomedullin for CADASIL).
Aeruginosin 98-BNot Available
AfamelanotideAn injectable subcutaneous implant used to mitigate phototoxicity secondary to erythropoietic protoporphyria (EPP).
Alanyl glutamineA dipeptide consisting of alanine and glutamine used for supplementation.
Albinterferon Alfa-2BInvestigated for use/treatment in hepatitis (viral, C).
AlbusomatropinAlbusomatropin has been used in trials studying the treatment of Growth Hormone-Deficiency and Growth Hormone Deficiency.
AldaferminAldafermin is under investigation in clinical trial NCT03912532 (Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study in Subjects With Nonalcoholic Steatohepatitis...
AldesleukinA recombinant analog of interleukin-2 used to induce an adaptive immune response in the treatment of renal cell carcinoma.
AlisporivirAlisporivir has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C.
AlmurtideAlmurtide is a small molecule drug. Almurtide has a monoisotopic molecular weight of 478.19 Da.
Alpha-1-proteinase inhibitorA purified form of human alpha-1 proteinase inhibitor used to treat emphysema patients with associated alpha-1 proteinase inhibitor deficiency.
AlsactideNot Annotated
ALT-801ALT-801 is under investigation in clinical trial NCT01478074 (ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia).
ALY688Not Available
AminocandinInvestigated for use/treatment in fungal infections.
Aminolevulinic acidA porphyrin precursor used to treat actinic keratosis of the face, scalp, and upper extremities, as well as to visualize a glioma.
AmlintideA medication used in combination with corticosteroids for the treatment of hemorrhoids.
AmphomycinNot Annotated
AMY-101AMY-101, also known as compstatin 40, is a peptidic inhibitor of the central complement component C3. AMY-101 is under investigation in clinical trial NCT03694444 (A Study of the C3 Complement...
AnakinraA recombinant form of human interleukin-1 receptor antagonist used in the treatment of rheumatoid arthritis, neonatal-onset multisystem inflammatory disease and deficiency of interleukin-1 receptor antagonist (DIRA).
AnamorelinInvestigated for use/treatment in cachexia and anorexia.
AnaritideNot Annotated
AncestimA human stem cell factor used in combination with filgrastim during autologous peripheral blood progenitor cell (PBPC) transplantation to increase PBPC mobilization for improved collection.
Angiotensin 1-7TXA127 has been investigated for the treatment of Miscellaneous Peripheral Blood Cell Abnormalities.
Angiotensin IIA peptide hormone of the RAAS system used to raise blood pressure in septic or other forms of shock.
AngiotensinamideNot Annotated
AnidulafunginAn antifungal used in the treatment of several types of candida infections.
AntipainAntipain is a serine/cysteine protease inhibitor originally isolated from various strains of actinomycetes. Early studies investigated the potential for antipain to alter DNA damage and chromosomal aberrations in irradiated cells...
Antithrombin III humanAn alpha-2-glycoprotein used to prevent thromboembolisms in patients with hereditary antithrombin III deficiency.
Anvatabart opadotinNot Annotated
AOD9604Investigated for use/treatment in obesity and osteoporosis.
AP-102Not Annotated
ApelinApelin is under investigation in clinical trial NCT03449251 (A Series of Pilot Studies to Evaluate the Haemodynamic and Metabolic Effects of Apelin and Relaxin).
Aprutumab ixadotinNot Annotated
ArgadinNot Available
ArgifinNot Available
Arginine glutamateTwo amino acids indicated in the treatment of hyperammonemia and in combination for total parenteral nutrition.
Arylomycin A2Not Available
Asg-5meNot Annotated
AspartameUsed as a diet supplement and sugar substitute.
Aspartyl-alanyl-diketopiperazineAspartyl-alanyl-diketopiperazine is under investigation in clinical trial NCT03349645 (An Open Label Extension Study to Assess the Safety of Long-Term Treatment With Ampion for Severe OA of the Knee).
AstodrimerAstodrimer has been used in trials studying the treatment and prevention of Bacterial Vaginosis. It is a lysine-based dendrimer with naphthalene disulfonic acid surface groups.
AtazanavirAn antiviral protease inhibitor used in combination with other antiretrovirals for the treatment of HIV.
AtilmotinAtilmotin is a small molecule drug. Atilmotin has a monoisotopic molecular weight of 1751.01 Da.
ATN-161Investigated for use/treatment in brain cancer and cancer/tumors (unspecified).
AtosibanAn inhibitor of oxytocin and vasopressin used to delay imminent preterm birth in pregnant adult women displaying specific clinical observations.
Atrial natriuretic peptideNot Annotated
AvexitideAvexitide is under investigation in clinical trial NCT02996812 (Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia).
AviptadilNot Annotated
AvizafoneAvizafone is a small molecule drug. The usage of the INN stem '-zafone' in the name indicates that Avizafone is a alozafone derivative. Avizafone has a monoisotopic molecular weight of...
AvoterminJuvista has been investigated for the treatment, prevention, and basic science of Scars, Keloid, and Cicatrix.
Azurin-p28Not Annotated
BacitracinA cyclic polypeptide antibiotic used to prevent wound infections, treat pneumonia and empyema in infants, and to treat skin and eye infections.
BalhimycinBalhimycin is a novel glycopeptide antibiotic.
BalixafortideBalixafortide is under investigation in clinical trial NCT03786094 (Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer).
BalugrastimBalugrastim has been used in trials studying the treatment of Solid Tumors.
BarusibanBarusiban has been used in trials studying the treatment of Infertility and In Vitro Fertilisation (IVF) Treatment.
Basic Fibroblast Growth FactorBasic Fibroblast Growth Factor is not currently approved for any FDA or Health Canada approved indications.
BasifunginBasifungin, also known as aureuobacidin A, is a phosphorylceramide synthase inhibitor , .
BecaplerminA recombinant form of human platelet-derived growth factor used to treat ulcers due to diabetic neuropathy in the lower extremities when there is adequate blood supply to the area.
BeinaglutideBeinaglutide is under investigation in clinical trial NCT03829891 (Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus).
BelnacasanInvestigated for use/treatment in inflammatory disorders (unspecified) and psoriasis and psoriatic disorders.
BempegaldesleukinBempegaldesleukin is under investigation in clinical trial NCT03729245 (A Study of NKTR-214 in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib...
BI-836858Not Annotated
BinetrakinBinetrakin has been used in trials studying the treatment of HIV Infections, Sarcoma, Kaposi, Non-Hodgkin's Lymphoma (NHL), Myelodysplastic Syndrome (MDS), and Leukemia, Acute Myelogenous (AML), among others.
BirinapantBirinapant has been investigated for the treatment of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML).
BivalirudinA direct thrombin inhibitor used to treat heparin-induced thrombocytopenia and to prevent thrombosis during percutaneous coronary intervention.
BizaxofuspNot Annotated
BleomycinA chemotherapy agent used to treat various malignancies, including head and neck malignancy, lymphoma, and testicular tumors, among others.
Bleomycin A2Bleomycin A2 is under investigation in clinical trial NCT00026208 (Combination Chemotherapy Plus Low-dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma).
Bleomycin A6Bleomycin A6 (also known as boanmycin) has been used in trials studying the treatment of Squamous Cell Lung Cancer. It was developed in China as an antineoplastic antibiotic. This drug...
BombesinBombesin is under investigation in clinical trial NCT01205321 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and...
BPC-157Bepecin is under investigation in clinical trial NCT02637284 (PCO-02 - Safety and Pharmacokinetics Trial).
BPI-3016BPI-3016 is under investigation in clinical trial NCT03188848 (Dose Escalating Study of BPI-3016 in Healthy Subjects).
BQ-123BQ-123 has been investigated for the basic science and treatment of Coronary Artery Disease, Aorto-coronary Bypass Grafting, and ST-Elevation Myocardial Infarction.
BQ-788Not Annotated
BradykininBradykinin has been investigated for the basic science and treatment of Hypertension and Diabetes Type 2.
BremelanotideBremelanotide is indicated to treat premenopausal women with hypoactive sexual desire disorder that is not due to a medical or psychiatric condition, problems with the relationship, or the effects of...
Brentuximab vedotinA CD30-directed antibody-drug conjugate used to treat various types of lymphoma.
BulevirtideA drug for the treatment of chronic Hepatitis D infection in adults with compensated liver disease.
BuserelinA LHRH agonist used for the palliative treatment of hormone-dependent advanced carcinoma of the prostate gland in males and treatment of endometriosis in females.
C-peptideC-peptide is under investigation in clinical trial NCT00278980 (Effect of C-peptide on Diabetic Peripheral Neuropathy).
C326Investigated for use/treatment in inflammatory disorders (unspecified).
CA-074 methyl esterCA-074 methyl ester (CA-074Me) is a cell-permeable cathepsin B inhibitor. It is converted by cellular esterases to CA-074.
CagrilintideCagrilintide is under investigation in clinical trial NCT06221969 (A Research Study to See How Much Cagrisema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2...
Calcitonin gene-related peptideInvestigated for use/treatment in myocardial infarction, heart disease, and asthma.
Calcium pangamateNot Annotated
CanfosfamideIntended for the treatment of various forms of cancer.
CaplacizumabA von Willebrand factor (vWF)-directed antibody fragment used to treat acquired thrombotic thrombocytopenic purpura (aTTP).
CapreomycinAn aminoglycoside antibiotic used as an adjunct drug in tuberculosis.
CarbetocinAn oxytocin agent used to control postpartum hemorrhage and bleeding after giving birth.
Cardiotrophin 1Not Annotated
CarfilzomibA proteasome inhibitor used either alone or in conjunction with a chemotherapy regimen to treat patients with relapsed or refractory multiple myeloma.
CargutocinCargutocin is a small molecule drug. Cargutocin has a monoisotopic molecular weight of 915.48 Da.
CarnosineCarnosine has been investigated for the treatment of Gulf War Illness.
CaspofunginAn echinocandin used to treat a variety of fungal infections.
CBP-501Not Annotated
CefilavancinInvestigated for use/treatment in bacterial infection, skin infections/disorders, and staph bacterial infections.
CemadotinCemadotin is a small molecule drug. Cemadotin has a monoisotopic molecular weight of 640.43 Da.
CenderitideCenderitide is under investigation for the treatment of ST Elevation (STEMI) Myocardial Infarction of Anterior Wall.
CenegerminA recombinant human nerve growth factor used to treat neurotrophic keratitis.
Certolizumab pegolA tumor necrosis factor (TNF) blocker used to treat a variety of autoimmune and autoinflammatory conditions like Crohn's disease, rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, and plaque psoriasis.
CeruletideCaerulein is used in the treatment of paralytic ileus and as diagnostic aid in pancreatic malfunction.
CetrorelixA synthetic peptide antagonist of gonadotropin releasing hormone used to prevent luteinizing hormone surges in women undergoing assisted reproduction therapy.
CHF5633CHF5633 is a fully synthetic pulmonary surfactant preparation comprising DPPC (dipalmitoylphosphatidylcholine), POPG Na (palmitoyl‐oleoyl‐phosphatidylglycerol sodium), a synthetic SP-C analogue, and a synthetic SP-B analogue.
CholecystokininFor use as a diagnostic aid for evaluation of gallbladder disorders. It is also used in conjunction with secretin in pancreatic insufficiency .
Chorionic Gonadotropin (Human)A naturally-occurring hormone produced during human placenta used for the treatment of prepubertal cryptorchidism and hypogonadotropic hypogonadism in selected males, and induction of pregnancy in selected infertile women.
ChymostatinNot Available
CibinetideCibinetide has been used in trials studying the basic science of Depression.
CIGB 300CIGB-300, is under investigation in clinical trials for its potential to treat various conditions, including NCT01639638 (recurrent and nonrecurrent condyloma) and NCT01639625 (squamous cell carcinoma and adenocarcinoma of the cervix)
CilofunginCilofungin is a small molecule drug. The usage of the INN stem '-fungin' in the name indicates that Cilofungin is a antifungal antibiotic. Cilofungin has a monoisotopic molecular weight of...
Cintredekin besudotoxInvestigated for use/treatment in brain cancer.
CMX-2043CMX-2043 has been used in trials studying the treatment and prevention of Non STEMI, Unstable Angina, Stable Coronary Artery Disease, and Percutaneous Coronary Intervention.
ColistimethateAn antibiotic indicated for treatment of infections caused by susceptible strains of certain gram-negative bacilli. It is particularly useful for targeting sensitive strains of Pseudomonas aeruginosa.
ColistinA polymyxin antibiotic used to treat bacterial infections caused by susceptible Gram negative bacteria.
Conestat alfaA recombinant C1INH used for the treatment of acute attacks of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency in adults.
Contulakin-GInvestigated for use/treatment in pain (acute or chronic).
Copper oxodotreotide Cu-64A Cu labeled somatostatin analog used in positron emission tomography to detect certain types of neuroendocrine tumors.
CorticorelinA synthetic corticotropin-releasing factor analog used to diagnose causes of excessive adrenocorticotropic hormone (ACTH) production.
Corticorelin ovine triflutateA synthetic corticotropin-releasing hormone used for diagnostic purposes in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome.
CorticotropinA diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency.
CR665Investigated for use/treatment in pain (acute or chronic).
CTB001CTB001 is an anti-claudin 18.2 autologous chimeric antigen receptor (CAR) T-cell therapy under investigation for the treatment of gastric cancers.
CTCE-0214Investigated for use/treatment in adverse effects (chemotherapy), blood (blood forming organ disorders, unspecified), cancer/tumors (unspecified), neutropenics, and vascular diseases.
Cyclo(his-pro)Not Available
Cyclo(prolylglycyl)NA-831 (Traneurocin), is under investigation in two clinical trials: NCT03538522 (completed, for mild cognitive impairment and Alzheimer’s disease) and NCT04452565 (unknown status, combination therapy with Atazanavir and Dexamethasone for COVID-19).
CyclosporineA steroid-sparing immunosuppressant used in organ and bone marrow transplants as well as inflammatory conditions such as ulcerative colitis, rheumatoid arthritis, and atopic dermatitis.
Cyclotheonamide ACyclotheonamide A is a cyclic peptide isolated from the marine sponge Theonella.
CYT006-AngQbInvestigated for use/treatment in hypertension.
DactinomycinAn actinomycin used to treat a wide variety of cancers.
DADLEA delta-selective opioid (ANALGESICS, OPIOID). It can cause transient depression of mean arterial blood pressure and heart rate.
DalanterceptDalantercept is under investigation in clinical trial NCT00996957 (Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma).
DalbavancinAn antibacterial used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible strains of Gram-positive bacteria.
DalfopristinAn antibiotic used with quinupristin to treat severe or life-threatening infections of vancomycin-resistant Enterococcus faecium (VREF), and skin infections caused by methicillin susceptible staphylococcus aureus or streptococcus pyogenes.
DanegaptideDanegaptide has been investigated for the treatment of Focus of Study is STEMI.
DapiclerminDapiclermin is a recombinant ciliary neurotrophic factor.
Dapirolizumab pegolDapirolizumab pegol is under investigation in clinical trial NCT02804763 (A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus).
DaptomycinA cyclic lipopeptide antibiotic used to treat complicated skin and skin structure infections by susceptible Gram-positive bacteria and bacteremia due to Staphylococcus aureus.
DarinaparsinInvestigated for use/treatment in blood (blood forming organ disorders, unspecified), cancer/tumors (unspecified), solid tumors, multiple myeloma, and liver cancer.
DasiglucagonA glucagon analog used to treat severe hypoglycemia in pediatric and adult patients with diabetes.
DavunetideDavunetide has been used in trials studying the treatment of Progressive Nonfluent Aphasia, Progressive Supranuclear Palsy, Predicted Tauopathies, Including, Corticobasal Degeneration Syndrome, and Frontotemporal Dementia With Parkinsonism Linked to Chromosome...
DegarelixA GnRH receptor antagonist used in the management of advanced prostate cancer.
DemoxytocinNot Annotated
Demplatin pegraglumerDemplatin pegraglumer is under investigation in clinical trial NCT02043288 (Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer).
Denileukin diftitoxAn IL2-receptor-directed cytotoxin indicated for the treatment of relapsed or refractory Stage I to III cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.
DepreotideDepreotide is an ingredient in the EMA-withdrawn product NeoSpect.
DesirudinIndicated as prophylaxis of deep vein thrombosis for patients undergoing hip replacement surgery.
DeslorelinDeslorelin acetate is an injectable gonadotropin releasing hormone super-agonist also known as an LHRH agonist. It stops the production of sex hormones.
DesmopressinA synthetic vasopressin (antidiuretic hormone) analog and $V_2$ receptor agonist used as replacement therapy for central diabetes insipidus, and as a prohemostatic agent to increase Factor VIII and von Willebrand factor levels in patients with Hemophilia A or Type 1 von Willebrand disease.
DetirelixDetirelix is a small molecule drug. The usage of the INN stem '-relix' in the name indicates that Detirelix is a gonadotropin-releasing-hormone (GnRH) inhibitor. Detirelix has a monoisotopic molecular weight...
Dialyzable leukocyte extractTransferon is comprised of several peptides mixed from human dialyzable leucocyte extracts and acts as an immunomodulator. It is thought to have widespread effects on the immune system, and effective...
DiaPep 277Investigated for use/treatment in diabetes mellitus type 1, autoimmune diseases, and diabetes mellitus type 2.
Dibotermin alfaindicated for the treatment of acute tibia fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation [FDA Label]. indicated for single-level...
DirucotideFor the treatment of multiple sclerosis (MS).
Disitamab vedotinDisitamab vedotin is an antibody-drug conjugate drug targeting human epidermal growth factor receptor 2 (HER2). It is currently being investigated for cancers.
DitekirenDitekiren is a small molecule drug. The usage of the INN stem '-kiren' in the name indicates that Ditekiren is a renin inhibitor. Ditekiren has a monoisotopic molecular weight of...
Dolastatin 10Dolastatin 10 has been used in trials studying the treatment of Sarcoma, Leukemia, Lymphoma, Liver Cancer, and Kidney Cancer, among others.
DopastatinDopastatin is under investigation in clinical trial NCT04335357 (TBR-760 in Adult Patients With Non-functioning Pituitary Adenomas).
Dotatate gallium Ga-68Dotatate gallium 68 is one of the most prominent radiopharmaceuticals used in imaging with positron emission tomography. It binds to the somatostatin-2 receptor which is usually overexpressed in many neuroendocrine...
DPDPEA heterodetic cyclic peptide that is a cyclic enkephalin analogue, having D-penicillaminyl residues located at positions 2 and 5, which form the heterocycle via a disulfide bond.
DulaglutideA GLP-1 agonist used to manage type 2 diabetes mellitus.
DulanerminDulanermin has been used in trials studying the treatment of Colorectal Cancer, Non-Hodgkin's Lymphoma, and Metastatic Colorectal Cancer.
DusquetideDusquetide has been used in trials studying the treatment of Oral Mucositis.
DynorphinDynorphin is under investigation in clinical trial NCT00000244 (Effects of Dynorphin 1-13 on Heroin Addiction - 1).
EA-230EA-230 is under investigation in clinical trial NCT03145220 (Immunomodulation of EA-230 Following On-pump Coronary Artery Bypass Grafting (CABG)).
EbiratideEbiratide is a small molecule drug. Ebiratide has a monoisotopic molecular weight of 995.53 Da.
EchinomycinEchinomycin is a cytotoxic polypeptide quinoxaline antibiotic isolated from Streptomyces echinatus that binds to DNA and inhibits RNA synthesis.
EDI-200EDI-200 is a fusion protein consisting of human immunoglobim G1 constant region Fc region fused to the human receptor binding domain of ectodysplasin-A1.
Edodekin alfaEdodekin alfa is under investigation in clinical trial NCT01468896 (Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That Is Recurrent, Metastatic, or...
EdotreotideNot Annotated
Edotreotide yttrium Y-90Not Annotated
EdratideEdratide is under investigation in clinical trial NCT00203151 (A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus).
Efbemalenograstim alfaA granulocyte-colony stimulating factor used to treat prevent chemotherapy-induced neutropenia.
EfegatranEfegatran is a small molecule drug. Efegatran has a monoisotopic molecular weight of 416.25 Da.
Efineptakin alfaEfineptakin alfa (also known as NT-I7) is a long-acting human interleukin-7 (IL-7) fusion protein that promotes T-cell development, contributing to the immune response. Compared to endogenous IL-7, NT-I7 is more...
EflapegrastimA form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy.
Eflepedocokin alfaEflepedocokin alfa is a recombinant IL-22-Fc fusion protein manufactured in Chinese hamster ovary cells that is composed of 2 human interleukin 22 (IL-22) molecules linked to an immunoglobulin constant region...
EfruxiferminEfruxifermin is under investigation in clinical trial NCT06215716 (A Study Evaluating Efruxifermin in Subjects With Non-cirrhotic Nonalcoholic Steatohepatitis (Nash)/metabolic Dysfunction-associated Steatohepatitis (MASH) and Fibrosis).
Eftansomatropin alfaEftansomatropin alfa (GX-H9) comprises a recombinant human growth hormone fused to hyFc, a synthetic hybrid Fc fragment. It is under investigation for the treatment of growth hormone deficiency.
Eftrenonacog alfaA recombinant Factor IX used to treat and prevent bleeding in hemophilia B.
EGEN-001Investigated for use/treatment in gene therapy and ovarian cancer.
ElafinInvestigated for use/treatment in inflammatory disorders (unspecified).
ElamipretideA mitochondrial cardiolipin binder used to improve muscle strength in patients with Barth syndrome.
ElcatoninNot Annotated
ElisidepsinElisidepsin is a small molecule drug. Elisidepsin has a monoisotopic molecular weight of 1476.93 Da.
ElobixibatElobixibat has been used in trials studying the treatment and basic science of Dyslipidemia, Constipation, Chronic Constipation, Functional Constipation, and Chronic Idiopathic Constipation.
EmfilerminInvestigated for use/treatment in adverse effects (chemotherapy), reproductive health, and infertility.
EmodepsideEmodepside is an anthelmintic drug that is effective against a number of gastrointestinal nematodes, is licensed for use in cats and belongs to the class of drugs known as the...
EnalaprilA prodrug of an ACE inhibitor used to treat hypertension and congestive heart failure.
EnalaprilatAn antihypertensive agent used for the management of hypertension when oral therapy is not practical.
EnalkirenNot Available
EnarodustatEnarodustat is under investigation in clinical trial NCT02581124 (Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease).
EndostarEndostar is under investigation for the treatment of Nasopharyngeal Carcinoma. Endostar has been investigated for the treatment of Non-small Cell Lung Cancer.
EndostatinInvestigated for use/treatment in cancer/tumors (unspecified), macular degeneration, and diabetic retinopathy.
Endothelin-1Endothelin 1 is under investigation in clinical trial NCT00745693 (The Effects of Diesel Exhaust Inhalation on Vascular Function - the Role of Endothelin).
EnfuvirtideAn HIV-1 gp41 fusion inhibitor used in patients experiencing HIV-1 replication who are already being treated with other anti-retrovirals.
EnviomycinCyclic basic peptide related to viomycin. It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.
EpitalonNot Annotated
Epoetin betaNot Annotated
Epoetin deltaEpoetin Delta is an ingredient in the EMA-withdrawn product Dynepo.
EptifibatideA peptide-based antagonist for glycoprotein IIb/IIIa used in the medical management of myocardial infarction and as an adjunct to percutaneous coronary intervention.
Eptotermin alfaA bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis. Eptotermin alfa is an ingredient in...
ErythropoietinA recombinant form of human erythropoietin used to increase differentiation of progenitor cells to red blood cells in the treatment of anemia.
EtanerceptA protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis.
EvorpaceptEvorpacept is under investigation in clinical trial NCT04755244 (A Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)).
ExamorelinExamorelin is a small molecule drug. The usage of the INN stem '-relin' in the name indicates that Examorelin is a pituitary hormone-release stimulating peptide. Examorelin has a monoisotopic molecular...
ExenatideA GLP-1 agonist used in the management of type 2 diabetes mellitus.
EzatiostatInvestigated for use/treatment in myelodysplastic syndrome.
FelypressinFor use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential.
Fibroblast growth factor-1Investigated for use/treatment in coronary artery disease and peripheral vascular disease.
FilgrastimA form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy.
FlovagatranInvestigated for use/treatment in thrombosis.
FollitropinA form of recombinant human follicle stimulating hormone used to stimulate follicle development in women with primary ovarian hypogonadism and in men with hypogonadotropic hypogonadism.
ForigerimodForigerimod is under investigation for the treatment of Lupus Erythematosus, Systemic.
FrakefamideNot Annotated
FusafungineFusafungine is an antibiotic from Fusarium lateririum, and is used for the treatment of respiratory infections.
G17DT ImmunogenIntended for the treatment of various forms of cancer.
GallichromeNot Available
gamma-GlutamylcysteineNot Available
GancotamabGancotamab is under investigation in clinical trial NCT02213744 (MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients).
GanirelixA GnRH antagonist used in assisted reproduction in women undergoing controlled ovarian hyperstimulation to control ovulation by inhibiting the premature LH surges.
Gastric inhibitory polypeptideGastric inhibitory polypeptide is under investigation in clinical trial NCT03081676 (The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea).
GB-115GB-115 is under investigation in clinical trial NCT05586789 (A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders).
GE-2270ANot Available
GlaspimodGlaspimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Glaspimod is a immunomodulator, both stimulant/suppressive and stimulant. Glaspimod has a monoisotopic...
GlatiramerAn immunomodulator used to reduce the frequency of relapses in Multiple Sclerosis (MS).
GLP-1 (7-36) amideGLP-1 (7-36) amide is under investigation in clinical trial NCT01185119 (Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET).
GlucagonA form of recombinant glucagon used to treat hypoglycemia in diabetes mellitus and as a part of gastrointestinal imaging procedures.
GlutathioneFor nutritional supplementation, also for treating dietary shortage or imbalance
Glutathione disulfideAn ingredient of ophthalmic irrigation solutions used during ophthalmological procedures.
GlutathionylspermidineNot Available
GlycylglutamineAn ingredient in amino acid solutions for parenteral nutrition.
GlycyltyrosineAn ingredient in amino acid solutions for parenteral nutrition.
GlyphosateNot Available
GlypromateInvestigated for use/treatment in neurologic disorders.
GolotimodInvestigated for use/treatment in hepatitis (viral, C), infectious and parasitic disease (unspecified), and tuberculosis.
GonadorelinA synthetic GnRH used to test the function of gonadotropes and the pituitary.
GontivimabGontivimab is under investigation in clinical trial NCT03468829 (Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) Infection).
Gonyautoxin IIGonyautoxin II is under investigation in clinical trial NCT04799041 (Gonyautoxin 2/3 in the Treatment of Acute Back Pain: A Clinical Proof-of-concept Study).
GoralatideGoralatide is a small molecule drug. Goralatide has a monoisotopic molecular weight of 487.23 Da.
GoserelinA synthetic analog of luteinizing hormone-releasing hormone used to treat breast cancer and prostate cancer by reducing secretion of gonadotropins from the pituitary.
Gramicidin DA bactericidal antibiotic used in the treatment of dermatological and ophthalmic infections.
Growth hormone-releasing peptide 1Growth hormone-releasing peptide 1 is under investigation in clinical trial NCT00381602 (A Phase II, Randomized, Cross-over, Vehicle-controlled, Double-blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in...
GS-9256GS-9256 has been used in trials studying the treatment of HCV Infection and Chronic Hepatitis C Infection.
GsMtx-4GsMtx-4 is a peptide found in tarantula venom that inhibits mechanosensitive ion channel (MSC) activity.
Hexapeptide-2Not Annotated
HiltonolNot Available
HistrelinA GnRH agonist found in subcutaneous implants used for the treatment of pediatric patients with central precocious puberty and the palliative treatment of advanced prostate cancer.
Human C1-esterase inhibitorA C1 inhibitor used to prevent angioedema attacks associated with hereditary angioedema.
Human interferon betaA polypeptide drug used in the treatment of relapsing forms of Multiple Sclerosis (MS).
Human Interleukin 8Interleukin-8 is under investigation in clinical trial NCT05148234 (BMS-986253 in Myelodysplastic Syndromes).
Human interleukin-2Human interleukin-2 is under investigation in clinical trial NCT03475134 (TIL-ACT After NMA Chemo With IL-2 and Nivo Rescue in mMEL).
Human interleukin-6Human interleukin-6 is under investigation in clinical trial NCT03170245 (Adiponectin, IL-6 and hsC-RP in Relation to Carotid Intima-media Thickness in B-thalassemia Patients).
IbodutantIbodutant has been used in trials studying the treatment of Irritable Bowel Syndrome and Irritable Bowel Syndrome With Diarrhea.
IcatibantA bradykinin B2 receptor antagonist used to treat acute episodes of swelling and inflammation associated with hereditary angioedema (HAE).
IcotrokinraA macrocyclic peptide and oral interleukin-23 receptor antagonist peptide indicated for the treatment of moderate-to-severe plaque psoriasis
IcrocaptideIcrocaptide is a small molecule drug. Icrocaptide has a monoisotopic molecular weight of 484.31 Da.
IlomastatIlomastat is a broad-spectrum matrix metalloproteinase inhibitor.
IMT-288IMT-288 is under investigation in clinical trial NCT01730638 (Immunotep for Patients With Medullary Thyroid Carcinoma.).
Indium In-111 pentetreotideIndium In 111 pentetreotide (Octreoscan) has been used in trials studying the diagnostic of SARCOIDOSIS, Solid Tumors, and cushing syndrome.
Indium In-111 satumomab pendetideFor diagnosis of extrahepatic malignant cancers
Insulin aspartA rapid-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus.
Insulin degludecA long acting insulin used to treat hyperglycemia caused by type 1 and 2 diabetes mellitus.
Insulin detemirA long-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus.
Insulin glargineA modified form of long-acting or basal insulin used to control hyperglycemia in diabetes mellitus.
Insulin glulisineA short-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus.
Insulin humanA recombinant form of human insulin used to control hyperglycemia in diabetes mellitus.
Insulin icodecAn ultra long-acting basal insulin analogue for once-weekly injection in patients with diabetes mellitus.
Insulin lisproA modified form of fast-acting insulin used to control hyperglycemia in diabetes mellitus.
Insulin peglisproNot Annotated
Insulin porkA purified form of porcine insulin used to control hyperglycemia in diabetes mellitus.
Insulin-like growth factor IIThe insulin-like growth factor II is a well-characterized neutral peptide believed to be secreted by the liver and to circulate in the blood. This factor presents effects related to growth...
Interferon alfaAn immunomodulator used to treat hepatitis B and C as well as certain types of cancer including cutaneous T-cell lymphoma and renal cell carcinoma.
Interferon alfa-1bNot Annotated
Interferon alfa-2aA form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses.
Interferon alfa-2bA form of recombinant human interferon used to treat hepatitis B and C infection, genital warts, hairy cell leukemia, follicular lymphoma, malignant melanoma, and AIDs-related Kaposi's sarcoma.
Interferon alfa-2cInterferon alfa-2c is under investigation in clinical trial NCT00485563 (A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma).
Interferon alfa-n1A purified form of human interferon used to stimulate the innate antiviral response in the treatment of genital warts due to human papilloma virus.
Interferon alfa-n3A purified form of human interferon used to stimulate the innate antiviral response in the treatment of genital warts due to human papilloma virus.
Interferon alfacon-1A recombinant interferon similar the interferon alfa subtype which is used to treat hepatitis C infections.
Interferon beta-1aA form of recombinant human interferon used to slow disease progression and reduce the frequency of clinical symptoms in patients who have relapsing multiple sclerosis.
Interferon beta-1bA form of recombinant human interferon used to slow the progression of relapsing multiple sclerosis and to reduce the frequency of clinical symptoms.
Interferon gamma-1bA form of recombinant human interferon used to treat infections associated with chronic granulomatous disease and to slow the progression of severe malignant osteopetrosis.
Interferon KappaInterferon kappa is a subclass of type I interferon mediating host defence which consists of 207 amino acids and has 30% homology with others of the same class as it...
Interferon tauNot Annotated
Interleukin-1 alpha, human recombinantNot Annotated
Interleukin-10Interleukin-10 has been used in trials studying the prevention and treatment of Vasculitis, Pancreatitis, Bile Duct Diseases, Pancreatic Diseases, and Gallbladder Diseases, among others.
Interleukin-15, human recombinantNot Annotated
Interleukin-7Interleukin 7 has been used in trials studying the treatment of Metastatic Breast Cancer.
IntermedineNot Annotated
IpafriceptIpafricept is under investigation in clinical trial NCT01608867 (A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors).
IpamorelinIpamorelin has been investigated for the treatment of Ileus.
IRX-2Investigated for use/treatment in cancer/tumors (unspecified), head and neck cancer, and solid tumors.
IsegananIseganan is under investigation in clinical trial NCT00022373 (Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer).
ISF402Investigated for use/treatment in diabetes mellitus type 2.
Isospaglumic acidIsospaglumic acid is a small molecule drug. Isospaglumic acid is under investigation in clinical trial NCT06800274 (Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With...
IturelixIturelix is a small molecule drug. The usage of the INN stem '-relix' in the name indicates that Iturelix is a gonadotropin-releasing-hormone (GnRH) inhibitor. Iturelix has a monoisotopic molecular weight...
JE-2147Not Available
KelatorphanNot Available
KisspeptinKisspeptin is under investigation in clinical trial NCT03315325 (Age-dependent Changes in the Responsiveness of Hypothalamic Pituitary Gonadal Axis in Men).
Kisspeptin-10Kisspeptin-10 is under investigation in clinical trial NCT03771326 (KP-10 and Insulin Secretion in Men).
LabradimilInvestigated for use/treatment in brain cancer and pediatric indications.
LagatideLagatide is a small molecule drug. Lagatide has a monoisotopic molecular weight of 738.44 Da.
LampalizumabLampalizumab has been used in trials studying the treatment of Geographic Atrophy.
LancovutideInvestigated for use/treatment in cystic fibrosis and eye disorders/infections.
LanreotideA somatostatin analog used for the treatment of unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors and acromegaly.
LarazotideInvestigated for use/treatment in autoimmune diseases, diabetes mellitus type 1, and gastrointestinal diseases and disorders (miscellaneous).
LenograstimA granulocyte colony-stimulating factor indicated in the reduction of duration of neutropenia in bone marrow transplant and cytotoxic chemotherapy, as well as mobilizing hematopoietic stem cells in healthy donors.
LenomorelinLenomorelin has been investigated for the treatment and basic science of Cancer, Alcoholism, Metabolism, Hypopituitarism, and Frailty Syndrome, among others.
LepirudinA protein-based direct thrombin inhibitor used as an anticoagulant in patients with heparin-induced thrombocytopenia.
LeptinInvestigated for use/treatment in lipodystrophy and obesity.
LeridistimLeridistim is under investigation in clinical trial NCT00004215 (Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia).
LeupeptinNot Annotated
LeuprolideA peptide-based GnRH receptor superagonist used for the palliative treatment of prostate cancer, uterine leiomyomata, endometriosis, and central precocious puberty.
LFF-571LFF571 has been used in trials studying the treatment of Moderate Clostridium Difficile Infection.
LipegfilgrastimA medication used to reduce the duration of chemotherapy-induced neutropenia and incidence of febrile neutropenia in cytotoxic chemotherapy.
LiraglutideA GLP-1 analog used in the management of type 2 diabetes mellitus, prevention of cardiovascular complications associated with diabetes, and obesity.
LisinoprilAn ACE inhibitor used to treat hypertension, heart failure, and acute myocardial infarction.
LivoletideLivoletide is under investigation in clinical trial NCT03790865 (Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome).
LonapegsomatropinA human growth hormone indicated in the treatment of growth failure due to inadequate endogenous growth hormone secretion.
Lorukafusp alfaLorukafusp alfa is under investigation in clinical trial NCT01334515 (Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma).
LotilibcinLotilibcin is a small molecule drug. Lotilibcin has a monoisotopic molecular weight of 1561.81 Da.
LTX-109LTX-109 has been investigated for the treatment of Atopic Dermatitis, Mild Eczema/Dermatoses, and Gram-positive, Skin Infections.
LucinactantIntended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.
LuspaterceptAn erythroid maturation agent used to treat anemia secondary to beta thalassemia, myelodysplastic syndromes, and neoplasms.
Luteinizing hormoneNot Annotated
Lutetium Lu 177 dotatateA radiolabeled somatostatin analog used to treat somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors.
Lutetium Lu177 EdotreotideNot Annotated
LypressinNot Annotated
Lys-plasminogenLys-plasminogen is a truncated form of natural human plasminogen.
Malacidin AMalacidin A is being investigated for its antibiotic action and has potential for use as an antibacterial agent in the future .
Malacidin BMalacidin B is being investigated for its antibiotic action and has potential for use as an antibacterial agent in the future .
MALP-2Not Annotated
Maxy-G34Investigated for use/treatment in adverse effects (chemotherapy) and neutropenics.
Mdl 101,146Not Available
MecapegfilgrastimMecapegfilgrastim is under investigation in clinical trial NCT05463601 (Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer).
MecaserminA recombinant insulin-like growth factor-1 used for the long-term treatment of growth failure in pediatric patients with primary IGF-1 deficiency or with growth hormone gene deletion due to the development of neutralizing antibodies to GH.
MenotropinsA purified combination of human luteinizing hormone and follicle stimulating hormone used to treat female infertility.
MetenkefalinAn investigational endogenous opioid being studied for the treatment of COVID-19.
Methoxy polyethylene glycol-epoetin betaA synthetic erythropoiesis stimulating agent (ESA) used to treat anemia associated with chronic kidney disease.
MetkephamidMetkephamid is a small molecule drug. Metkephamid has a monoisotopic molecular weight of 600.27 Da.
MetreleptinA leptin analogue used as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients various forms of lipodystrophy.
MGB-BP-3Mgb Bp 3 is under investigation in clinical trial NCT02518607 (Safety, Blood Levels and Effects of MGB-BP-3).
MibenratideMibenratide is under investigation in clinical trial NCT01798745 (A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies).
MicafunginAn antifungal agent used for the treatment of candidemia, acute disseminated candidiasis, and certain other invasive Candida infections, and for the prophylaxis of Candida infections during stem cell transplantation.
MifamurtideA muramyl dipeptide derivative used to treat high grade, resectable, non-metastatic osteosarcoma after surgical resection.
MinigastrinMinigastrin is under investigation in clinical trial NCT06155994 (68ga-dota-mgs5 PET/CT in Patients With Advanced Neuroendocrine Tumours).
MM3122Not Annotated
MolgramostimMolgramostim has been used in trials studying the treatment of Bronchiectasis, Cystic Fibrosis, Pulmonary Alveolar Proteinosis, Acute Respiratory Distress Syndrome, and Autoimmune Pulmonary Alveolar Proteinosis.
MontirelinMontirelin is a small molecule drug. The usage of the INN stem '-tirelin' in the name indicates that Montirelin is a thyrotropin releasing hormone analogue. Montirelin has a monoisotopic molecular...
MotixafortideA peptide inhibitor of CXCR4 used to mobilize hematopoietic stem cells prior to collection and autologous transplantation in multiple myeloma patients.
MotuporinMotuporin is a toxin isolated from the marine sponge Thenonella swinhoie grey.
MuplestimMuplestim is under investigation in clinical trial NCT00002258 (A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in...
MurabutideMurabutide is a small molecule drug. Murabutide has a monoisotopic molecular weight of 548.27 Da.
MurepavadinMurepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment).
N-(1-carboxy-3-phenylpropyl)phenylalanyl-alpha-asparagineNot Available
N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-ProlineNot Available
N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanineNot Available
NacartocinNacartocin is a small molecule drug. Nacartocin has a monoisotopic molecular weight of 985.51 Da.
NafarelinA gonadotropin releasing hormone agonist used to treat central precocious puberty.
NagrestipenNagrestipen has been used in trials studying the treatment of CANCER, Neoplasm, Metastasis, Radiation Oncology, and Neoplasm Metastasis.
NangibotideNangibotide is under investigation in clinical trial NCT04055909 (Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock).
NavepegritideA C-type natriuretic peptide (CNP) prodrug used to increase linear growth in pediatric patients with achondroplasia and open epiphyses.
NBI-6024Investigated for use/treatment in diabetes mellitus type 1 and pediatric indications.
Neladenoson bialanateNeladenoson bialanate has been investigated for the treatment of Heart Failure.
Nelipepimut-SInvestigated for use/treatment in prostate cancer and breast cancer.
NepadutantNepadutant has been used in trials studying the treatment of Colic, Infantile Colic, and Infantile Functional Gastrointestinal Disorders.
NepiderminNot Annotated
NerinetideNa 1 is under investigation in clinical trial NCT00728182 (Evaluating Neuroprotection in Aneurysm Coiling Therapy).
Nerve Growth FactorNerve Growth Factor has been used in trials studying the prevention and treatment of Mental Handicap, Alzheimer's Disease, Traumatic Brain Injury, Cerebral Palsy Children, and Delayed Speech Development, among others.
NesiritideA recombinant natriuretic peptide used for the treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity.
Neuropeptide YNeuropeptide Y is under investigation for the basic science of Type 2 Diabetes Mellitus.
Nisin ZNisin Z is under investigation in clinical trial NCT06097468 (Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)).
Nitrilotriacetic acidNitrilotriacetic acid is a derivative of acetic acid, N(CH2COOH)3. It is a complexing (sequestering) agent that forms stable complexes with Zn2+. (From Miall's Dictionary of Chemistry, 5th ed.)
NN344Investigated for use/treatment in diabetes mellitus type 1 and 2.
NNZ-2591NNZ-2591 (cyclo-L-glycyl-L-2-allylproline) is an investigational synthetic analog of cyclic glycine-proline (cGP), a breakdown product of human insulin-like growth factor 1 (IGF-1), that has been chemically modified to increase its half-life,...
Nogapendekin alfaAn IL-15 receptor agonist used to treat BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumours.
Nona-arginineNona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs (PATENT)).
NonathymulinNonathymulin is a small molecule drug. Nonathymulin has a monoisotopic molecular weight of 858.38 Da.
NOV-002Investigated for use/treatment in breast cancer, lung cancer, and ovarian cancer.
NovaferonNot Available
NRP-2945NRP-2945 is a 11-mer peptidomimetic.
OBP-801OBP-801 has been used in trials studying the treatment of Solid Tumor.
OcriplasminA proteolytic enzyme used to treat symptomatic vitreomacular adhesion by dissolving the protein matrix responsible for the adhesion between the vitreous and macula.
OctreotideA peptide drug used to treat acromegaly as well as diarrhea associated with metastatic carcinoid tumors and vasoactive intestinal peptide secreting tumors.
OglufanideInvestigated for use/treatment in hepatitis (viral, C).
OlcegepantFor the treatment of migraine headaches.
OmberacetamOmberacetam is a small molecule drug. The usage of the INN stem '-racetam' in the name indicates that Omberacetam is a piracetam type amide type nootrope agent. Omberacetam has a...
OmigananInvestigated for use/treatment in bacterial infection and rosacea.
OprelvekinA form of recombinant interleukin-11 used to stimulate production of megakaryocytes and platelets in patients with or at risk of thrombocytopenia after chemotherapy.
OprozomibOprozomib has been used in trials studying the treatment of Solid Tumors, Multiple Myeloma, Waldenstrom Macroglobulinemia, Advanced Hepatocellular Carcinoma, and Advanced Non-Central Nervous System (CNS) Malignancies.
OritavancinAn antibacterial agent used to treat acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria.
OrnipressinNot Annotated
OrnithineAn amino acid commonly found as a component in total parenteral nutrition.
OrotirelinOrotirelin is a small molecule drug. The usage of the INN stem '-tirelin' in the name indicates that Orotirelin is a thyrotropin releasing hormone analogue. Orotirelin has a monoisotopic molecular...
Ostabolin-CInvestigated for use/treatment in menopause and osteoporosis.
OxeclosporinOxeclosporin is a small molecule drug. The usage of the INN stem '-(clo)sporin' in the name indicates that Oxeclosporin is a cyclosporine derivative. Oxeclosporin has a monoisotopic molecular weight of...
OxytocinA recombinant hormone used to induce or strengthen uterine contractions in pregnant women to aid in labor and delivery or to control postpartum bleeding.
OzarelixOzarelix has been used in trials studying the treatment of Prostate Cancer, Benign Prostatic Hypertrophy, and Benign Prostatic Hyperplasia (BPH).
P-113DFor the potential treatment of cystic fibrosis and bacterial infections.
PACAP38Not Available
Paclitaxel poliglumexNot Annotated
PaliferminA form of recombinant human keratinocyte growth factor used to prevent and treat oral mucositis following radiation or chemotherapy.
PalopegteriparatideA parathyroid hormone analog used to treat hyperparathyroidism in adults.
Pam2csk4Not Available
Pancreatic PolypeptidePancreatic Polypeptide has been investigated for the treatment of Diabetes Mellitus, Type 1.
Parathyroid hormoneAn analog of human parathyroid hormone (PTH) used to treat hypocalcemia caused by hypoparathyroidism.
Parathyroid Hormone-Related Protein 1-36Parathyroid Hormone-Related Protein 1-36 is under investigation in clinical trial NCT00853723 (Comparison Study of Pthrp and PTH to Treat Osteoporosis).
PareptidePareptide is a small molecule drug. Pareptide has a monoisotopic molecular weight of 298.2 Da.
PasireotideA somatostatin analog used in the treatment of Cushing’s disease, specifically for those patients whom pituitary surgery is not appropriate.
PegbelferminPegbelfermin is under investigation in clinical trial NCT03486899 (A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis).
PegcetacoplanA complement inhibitor indicated in the treatment of adults with paroxysmal nocturnal hemoglobinuria.
PegdinetanibInvestigated for use/treatment in cancer/tumors (unspecified) and macular degeneration.
PegfilgrastimA recombinant human granulocyte colony stimulating factor used to stimulate the production of neutrophils and prevent febrile neutropenia or infections after myelosuppressive chemotherapy.
PegilodecakinPegilodecakin is under investigation in clinical trial NCT03382912 (Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer).
Peginterferon alfa-2aA modified form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses.
Peginterferon alfa-2bA purified form of human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C, genital warts, and some cancers.
Peginterferon beta-1aAn interferon beta used to treat relapsing forms of multiple sclerosis.
Peginterferon lambda-1aPeginterferon lambda-1a is under investigation in clinical trial NCT01754974 (Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C).
PegmusirudinPegmusirudin is under investigation in clinical trial NCT00074620 (A Clinical Study to Assess the Safety of Peg-hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis).
PegvisomantA growth hormone receptor antagonist used to treat acromegaly.
Pegylated synthetic human c-peptideNot Annotated
PendetidePendetide is a small molecule drug. Pendetide has a monoisotopic molecular weight of 741.32 Da.
PentagastrinA gastrin-like molecule used as a diagnostic aid for the evaluation of gastric acid secretory function, gastric hypersecretion, and Zollinger-Ellison tumors.
PentetreotideA somatostatin receptor inhibitor, available in a kit with Indium-111, used as a contrast agent in the visualization of somatostatin receptor-positive neuroendocrine tumours.
PentigetidePentigetide is a small molecule drug. The usage of the INN stem '-igetide' in the name indicates that Pentigetide is a peptide and glycopeptide. Pentigetide has a monoisotopic molecular weight...
PepstatinPepstatin is a small molecule drug. Pepstatin has a monoisotopic molecular weight of 685.46 Da.
Peptide YY (1-36)Not Available
Peptide YY (3-36)Investigated for use/treatment in metabolic disease and obesity.
Peptide-TPeptide-T is under investigation in clinical trial NCT00000392 (Phase II Study of the Efficacy of Peptide T in Hiv-positive Individuals With Cognitive Impairment.).
PexelizumabFor the treatment of inflammation during cardiac surgery.
PexigananPexiganan is under investigation in clinical trial NCT01594762 (Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers).
PhosphoramidonNot Available
PirnabinePirnabine has been used in trials studying the treatment of Chronic Idiopathic Constipation.
PL-3994PL-3994 is under investigation in clinical trial NCT01304628 (Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma).
PlecanatideA laxative used to treat chronic idiopathic constipation and IBS with constipation.
PlitidepsinIntended for the treatment of various forms of cancer.
PM02734Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors.
PMX-205Not Annotated
PolaprezincPeptic ulcer disease, dyspepsia .
PolygelineA medication used for plasma volume expansion.
Polymyxin BA polymyxin antibiotic used to treat a wide variety of infections in the body.
PosatirelinPosatirelin is a small molecule drug. The usage of the INN stem '-tirelin' in the name indicates that Posatirelin is a thyrotropin releasing hormone analogue. Posatirelin has a monoisotopic molecular...
PR-15Investigated for use/treatment in atherosclerosis and thrombosis.
PralmorelinNot Annotated
PramlintideAn amylin analog used for the management of type 1 and type 2 diabetes mellitus as an adjunct to preprandial insulin therapy in patients without adequate glycemic control of insulin therapy.
PrezatideCommonly used in cosmetic products for the skin and hair .
PristinamycinNot Annotated
PRO-542Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections, HIV infection, and pediatric indications.
ProcalcitoninProcalcitonin is under investigation in clinical trial NCT03440060 (Procalcitonin-guided Antibiotic Therapy During Severe Exacerbation of COPD).
ProgranulinNot Available
Proinsulin humanNot Annotated
ProtirelinA synthetic analogue of thyrotropin-releasing hormone that has been used during diagnostic tests to evaluate function of the thyroid gland.
QuinupristinAn antibiotic agent used in the treatment of serious vancomycin-resistant Enterococcus faecium bacteremia as well as complicated skin and skin structure infections.
RamoplaninFor the treatment of bacterial infections.
RamorelixRamorelix is a small molecule drug. The usage of the INN stem '-relix' in the name indicates that Ramorelix is a gonadotropin-releasing-hormone (GnRH) inhibitor. Ramorelix has a monoisotopic molecular weight...
RapastinelRapastinel has been used in trials studying the treatment of Depressive Disorder, Major and Obsessive-Compulsive Disorder (OCD).
Recombinant Alpha-1-antitrypsinNot Annotated
Recombinant CD40-ligandRecombinant CD40-ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).
Recombinant human plasma gelsolinPlasma gelsolin (pGSN) is a protein found in the blood of healthy individuals which scavenges compounds left over from damaged tissues.
RegramostimInvestigated for use/treatment in adverse effects (chemotherapy) and bone marrow transplant.
RelamorelinRelamorelin has been investigated for the treatment and basic science of Gastroparesis, Gastric Motility, Diabetes Mellitus, Parkinson's Disease, and Chronic Constipation, among others.
RencofilstatNot Annotated
RepiferminInvestigated for use/treatment in bone marrow transplant, ulcers, and inflammatory bowel disease.
Revakinagene taroretcelAn allogeneic encapsulated cell-based gene therapy used to treat idiopathic macular telangiectasia type 2 in adults.
Reversin 121Reversin 121 is a hydrophobic peptide chemosensitizer that can reverse P-glycoprotein-mediated multidrug resistance.
RezafunginAn echinocandin antifungal indicated in patients over 18 years old who have limited or no alternative options for the treatment of candidemia and invasive candidiasis.
RomidepsinA histone deacetylase (HDAC) inhibitor used to treat cutaneous T-cell lymphoma.
RomiplostimA fusion protein thrombopoietin (TPO) peptide analog that increases platelet counts by binding to and activating the human TPO receptor. Used to treat thrombocytopenia associated with chronic immune thrombocytopenia (ITP).
RomurtideRomurtide is a small molecule drug. Romurtide has a monoisotopic molecular weight of 886.56 Da.
Ropeginterferon alfa-2bA mono-pegylated type I interferon used to treat polycythemia vera.
RopocamptideRopocamptide is a human cathelicidin that inhibits viral replication and while also playing a role in host defense against infection.
RotigaptideRotigaptide is under investigation for the basic science of Heart Disease and Vascular Disease.
RuclosporinRuclosporin is a small molecule drug. The usage of the INN stem '-(clo)sporin' in the name indicates that Ruclosporin is a cyclosporine derivative. Ruclosporin has a monoisotopic molecular weight of...
Rusalatide acetateChrysalin has been used in trials studying the treatment of Radius Fracture.
RuxotemitideLTX-315 has been used in trials studying the treatment of Cancer, Lymphoma, Melanoma, Carcinoma, and Breast Cancer, among others.
RWJ-800088RWJ-800088 is a synthetic PEGylated thrombopoietin (TPO) mimetic (TPOm) peptide with no sequence homology to endogenous TPO.
S-(2,4-dinitrophenyl)glutathioneNot Available
S-(4-nitrobenzyl)glutathioneNot Available
S-(N-hydroxy-N-bromophenylcarbamoyl)glutathioneNot Available
S-benzylglutathioneNot Available
S-HexylglutathioneNot Available
S-Methyl glutathioneNot Available
S-NitrosoglutathioneNot Annotated
S-octylglutathioneNot Available
Salmon calcitoninA synthetic peptide form of calcitonin used to inhibit bone resorption in the treatment of hypercalcemia, osteoporosis, and Paget's disease.
Sar9, Met (O2)11-Substance PInvestigated for use/treatment in acute respiratory distress syndrome (ARDS) and viral infection.
SaralasinNot Annotated
SargramostimA modified form of recombinant human granulocyte-macrophage colony stimulating factor used to increase immune cell production after myelosuppressive therapy or bone marrow transplant.
SaxagliptinAn DPP-4 inhibitor used for the management of type 2 diabetes mellitus.
SCY-635SCY-635 has been investigated for the treatment of Chronic Hepatitis C and Hepatitis C Infection.
Secretin humanA secretin hormone used to stimulate pancreatic or gastric secretions to diagnose exocrine pancreas dysfunction, gastrinoma, and abnormalities in the bile and pancreatic ducts.
SelepressinSelepressin has been used in trials studying the treatment of Septic Shock.
SemaglutideA glucagon-like peptide 1 receptor agonist used to improve glycemic control in type 2 diabetes mellitus, treat obesity, and reduce the risk of major adverse cardiovascular events in selected adults.
SemparatideSemparatide is a small molecule drug. The usage of the INN stem '-paratide' in the name indicates that Semparatide is a parathyroid hormone analogue. Semparatide has a monoisotopic molecular weight...
SER-100SER-100 is under investigation in clinical trial NCT01987284 (SER100 in Isolated Systolic Hypertension).
SermorelinFor the treatment of dwarfism, prevention of HIV-induced weight loss
SetmelanotideA drug indicated to treat obesity caused by genetic POMC, PCSK1, or LEPR deficiencies or Bardet-Biedl syndrome.
SF1126For the treatment of various forms of cancer.
SincalideA diagnostic agent used to stimulate gallbladder contraction or pancreatic secretion during diagnostic tests, and accelerate fluoroscopy and x-ray examination of the intestinal tract.
Skf 107457Not Available
SoblidotinSoblidotin has been used in trials studying the treatment of Sarcoma, Lung Cancer, and Unspecified Adult Solid Tumor, Protocol Specific.
SolnatideSolnatide has been used in trials studying the treatment of Acute Lung Injury.
SomapacitanA human growth hormone analog subcutaneous injection indicated for adults with growth hormone deficiency.
SomatorelinA synthetic version of growth hormone-releasing hormone used in the diagnosis of growth hormone deficiency.
SomatostatinA natural peptide hormone used to treat acute bleeding from esophageal varices, gastrointestinal ulcers, and gastritis; prevent pancreatic complications after surgery; and restrict secretions of the upper intestine, pancreas, and biliary tract.
SomatotropinA recombinant human growth hormone used as replacement therapy in various conditions of growth failure, growth hormone deficiency, and weakness in children and adults.
SomatremA recombinant growth hormone used to treat adult growth hormone deficiency and treat disrupted growth in children due to growth hormone insufficiency or deficiency, turner's syndrome, chronic renal failure, and small stature for gestational age.
SomatrogonA long-acting recombinant human growth hormone used as the long-term treatment of pediatric patients who have growth failure due to growth hormone deficiency.
Somatropin pegolSomatropin pegol is under investigation in clinical trial NCT00715689 (Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083).
SonelokimabSonelokimab is under investigation in clinical trial NCT06411379 (Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa).
SovateltideInvestigated for use/treatment in cancer/tumors (unspecified).
SpiraprilSpirapril is an ACE inhibitor class drug used to treat hypertension.
SpriferminSprifermin has been used in trials studying the treatment of Osteoarthritis, Knee and Cartilage Injury of Knee.
ST-003ST-003 is a novel galanin receptor inhibitor being investigated for the treatment of primary sclerosing cholangitis.
StallimycinStallimycin is a small molecule drug. The usage of the INN stem '-mycin' in the name indicates that Stallimycin is a antibiotic, produced by Streptomyces strain. Stallimycin has a monoisotopic...
Substance PSubstance P is under investigation in clinical trial NCT03738878 (Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1).
SulglicotideNot Annotated
SurotomycinSurotomycin has been used in trials studying the treatment of Diarrhea and Clostridium Difficile Infection. It is a benzenebutanoic acid derivative patented by Cubist Pharmaceuticals, Inc. as antibacterial agents for...
TabimorelinTabimorelin is a small molecule drug. The usage of the INN stem '-relin' in the name indicates that Tabimorelin is a pituitary hormone-release stimulating peptide. Tabimorelin has a monoisotopic molecular...
TAK-448TAK-448 has been used in trials studying the treatment of Prostate Cancer, Low Testosterone, Prostatic Neoplasms, and Hypogonadotropic Hypogonadism.
TalabostatInvestigated for use/treatment in lymphoma (non-hodgkin's), leukemia (lymphoid), lung cancer, melanoma, and pancreatic cancer.
TallimustineAn alkylating agent previously investigated for it's antitumor activity but was stopped due to severe myelotoxicity.
TaltirelinTaltirelin is a small molecule drug. The usage of the INN stem '-tirelin' in the name indicates that Taltirelin is a thyrotropin releasing hormone analogue. Taltirelin has a monoisotopic molecular...
TaltobulinTaltobulin is a small molecule drug. Taltobulin has a monoisotopic molecular weight of 473.33 Da.
TasidotinTasidotin is a small molecule drug. Tasidotin has a monoisotopic molecular weight of 606.45 Da.
TeceleukinTeceleukin is under investigation in clinical trial NCT03610490 (Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Osteosarcoma, or Pancreatic Ductal Adenocarcinoma).
Technetium Tc-99m maraciclatideNot Annotated
TeicoplaninA glycopeptide antibiotic with a similar mechanism of action and spectrum of activity to vancomycin used to treat various infections caused by gram-positive bacteria.
TelaprevirAn NS3/4A viral protease inhibitor used in combination with other antivirals for the curative treatment of chronic Hepatitis C Virus infections.
TelavancinAn antibacterial agent used in the treatment of complicated skin and skin structure infections and types of hospital-acquired bacterial pneumonia.
TengonerminTengonermin, also known as NGR-hTNF, is a vascular-targeting drug. It is a recombinant protein and peptide-targeted agent consisting of the human Tumour Necrosis Factor-α (TNF-α) conjugated with the CNGRCG peptide....
TeriparatideA recombinant parathyroid hormone used for the treatment of osteoporosis.
TerlakirenTerlakiren is a small molecule drug. The usage of the INN stem '-kiren' in the name indicates that Terlakiren is a renin inhibitor. Terlakiren has a monoisotopic molecular weight of...
TerlipressinA drug used to treat bleeding caused by esophageal varices.
TesamorelinA growth hormone releasing factor (GRF) analog used to reduce excessive abdominal fat in HIV patients who have developed lipodystrophy.
TetracosactideA diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency.
TeverelixInvestigated for use/treatment in benign prostatic hyperplasia, endometriosis, and prostate cancer.
ThiostreptonThiostrepton is a natural cyclic oligopeptide antibiotic, derived from several strains of streptomycetes including Streptomyces azureus and Streptomyces laurentii. Thiostrepton is a natural product of the ribosomally synthesized and post-translationally...
THR-184THR-184 is under investigation in clinical trial NCT01830920 (A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-acute Kidney Injury (CSA-AKI)).
ThrombopoietinInvestigated for use/treatment in thrombocytopenia.
ThymalfasinIndicated as an adjuvant for influenza vaccine in elderly patients and as an adjuvant for both influenza and hepatitis B vaccines in chronic hemodialysis patients who failed to achieve adequate...
ThymocartinThymocartin is a small molecule drug. Thymocartin has a monoisotopic molecular weight of 516.3 Da.
ThyrotropinA medication indicated in thyroid stimulation before radioactive iodine ablation or for thyroid imaging.
TifuvirtideInvestigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections and HIV infection.
TigapotideFor the treatment of late stage Hormone Refractory Prostate Cancer (HRPC) for which no effective therapy currently exists.
TimbetasinTimbetasin is under investigation in clinical trial NCT05555589 (Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2).
TiplimotideTiplimotide has been used in trials studying the treatment of Multiple Sclerosis.
TirzepatideA dual GIP and GLP-1 receptor agonist used for the treatment of type II diabetes in adults as an adjunct to diet and exercise.
Tisotumab vedotinA tissue factor-directed antibody drug conjugate that is used to treat adults with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
TP-3654Not Annotated
TraferminInvestigated for use/treatment in coronary artery disease, peripheral vascular disease, periodontal disease, bone fractures, entero-related fistulae, and diabetic foot ulcers.
Tralesinidase alfaTralesinidase alfa is a chimeric fusion protein comprised of recombinant human NAGLU and a modified human insulin-like growth factor 2. It is being investigated for the treatment of mucopolysaccharidosis type...
TriletideTriletide is a small molecule drug. Triletide has a monoisotopic molecular weight of 505.23 Da.
TriptorelinA GnRH agonist indicated for the palliative treatment of advanced prostate cancer.
TrofinetideA drug used to treat Rett syndrome in children and adults.
TRV-120027TRV120027 has been used in trials studying the treatment of Heart Failure and Kidney Disease.
TrypanothioneNot Available
TT-232Tln 232 is under investigation in clinical trial NCT00422786 (Phase II Study of CAP-232 in Patients With Refractory Metastatic Renal Cell Carcinoma).
Tucotuzumab celmoleukinTucotuzumab celmoleukin is under investigation in clinical trial NCT00016237 (Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous...
TyroserleutideNot Annotated
TyrothricinA topical antibiotic with broad spectrum activity against Gram positive bacteria and some fungal infections.
UlaritideInvestigated for use/treatment in congestive heart failure.
Urocortin-2Urocortin 2 has been investigated for the basic science of Heart Failure and Cardiovascular Disease.
UrofollitropinA form of purified human follicle stimulating hormone used to treat infertility in females by inducing follicle development in women without primary ovarian failure.
ValinomycinA cyclododecadepsipeptide ionophore antibiotic produced by Streptomyces fulvissimus and related to the enniatins. It is composed of 3 moles each of L-valine, D-alpha-hydroxyisovaleric acid, D-valine, and L-lactic acid linked alternately...
ValspodarValspodar has been used in trials studying the treatment of Cancer, Sarcoma, Leukemia, Lymphoma, and Breast Cancer, among others.
VancomycinA glycopeptide antibiotic used to treat severe but susceptible bacterial infections such as MRSA (methicillin-resistant Staphylococcus aureus) infections.
VapreotideFor the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and has also shown efficacy in the treatment of patients with AIDS-related diarrhea.
Vasoactive intestinal peptideNot Annotated
VasomeraNot Available
VasopressinA peptide hormone used to increase blood pressure in patients with vasodilatory shock who are resistant to fluid and catecholamine therapy.
VEGFR2-169VEGFR2-169 is under investigation in clinical trial NCT00655785 (Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)).
VelaferminInvestigated for use/treatment in adverse effects (chemotherapy).
VeldoreotideSomatoprim is under investigation for the treatment of Acromegaly.
ViomycinViomycin is an essential component in the drug cocktail currently used to fight infections of Mycobacterium tuberculosis.
Vipivotide tetraxetanNot Annotated
ViquidacinViquidacin is a small molecule drug. The usage of the INN stem '-dacin' in the name indicates that Viquidacin is a antibiotic, DNA gyrase and topoisomerase IV inhibitor. Viquidacin has...
Viral Macrophage-Inflammatory ProteinViral macrophage inflammatory protein-II (vMIP) is a highly basic protein and human chemokine analog encoded by human herpesvirus-8. The structure of vMIP consists of 71 residues and is a monomer...
VirginiamycinVirginiamycin is a streptogramin antibiotic similar to pristinamycin and quinupristin/dalfopristin. It is a combination of pristinamycin IIA and virginiamycin S1. Virginiamycin is used in the fuel ethanol industry to prevent...
Virginiamycin M1For the treatment of bacterial infections.
Virginiamycin S1One of the components of virginiamycin, a cyclic polypeptide antibiotic complex from streptomyces virginiae, s. Loidensis, s. Mitakaensis, s. Pristina-spiralis, s. Ostreogriseus, and others. It is used to treat infections...
VL-2397Not Annotated
VM4-037VM4-037 is under investigation in clinical trial NCT00884520 (An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037).
VobarilizumabVobarilizumab is under investigation in clinical trial NCT02101073 (ALX-0061 Phase I Bioavailability Study in Healthy Volunteers).
VoclosporinA calcineurin inhibitor for the treatment of lupus nephritis (LN) in patients diagnosed with systemic lupus erythematosus (SLE).
VolpristinVolpristin is a small molecule drug. Volpristin has a monoisotopic molecular weight of 527.26 Da.
VosoritideAn analogue of C-type naturietic peptide used to promote bone growth in pediatric patients with achondroplasia.
XempritolimodNot Annotated
XPro1595XPro1595 is an investigational dominant-negative protein that neutralizes soluble TNF.
Z-Pro-ProlinalNot Available
ZilucoplanA complement inhibitor used to treat generalized myasthenia gravis in anti-acetylcholine receptor (AChR) antibody-positive adults.
Zoptarelin doxorubicinZoptarelin doxorubicin has been used in trials studying the treatment of Breast Cancer, Ovarian Cancer, Prostate Cancer, Endometrial Cancer, and Urothelial Carcinoma, among others.
Drugs & Drug Targets
DrugTargetType
.gamma.-brain natriuretic peptideAtrial natriuretic peptide receptor 1target
9-(N-methyl-L-isoleucine)-cyclosporin APeptidyl-prolyl cis-trans isomerase F, mitochondrialtarget
9-(N-methyl-L-isoleucine)-cyclosporin APeptidyl-prolyl cis-trans isomerase Atarget
AbaloparatideParathyroid hormone/parathyroid hormone-related peptide receptortarget
AbarelixGonadotropin-releasing hormone receptortarget
AbciximabIntegrin beta-3target
AbciximabLow affinity immunoglobulin gamma Fc region receptor II-atarget
AbciximabLow affinity immunoglobulin gamma Fc region receptor II-btarget
AbciximabIntegrin alpha-IIbtarget
AbciximabVitronectintarget
ABT-510Thrombospondin-1target
ABT-510Interleukin-8target
ABT-510Vascular endothelial growth factor A, long formtarget
ABT-510Hepatocyte growth factortarget
ABT-510Fibroblast growth factor 2target
Acetyl hexapeptide-3Synaptosomal-associated protein 25target
acetylleucyl-leucyl-norleucinalProteasome subunit alpha type-7target
AclerastideProto-oncogene Mastarget
AcylineGonadotropin-releasing hormone receptortarget
AdrenomedullinCalcitonin gene-related peptide type 1 receptortarget
AdrenomedullinNeprilysinenzyme
Aeruginosin 98-BSerine protease 1target
AfamelanotideMelanocyte-stimulating hormone receptortarget
AfamelanotideMelanocortin receptor 4target
Albinterferon Alfa-2BCytochrome P450 1A2enzyme
AlbusomatropinGrowth hormone receptortarget
AldesleukinInterleukin-2target
AldesleukinCytochrome P450 2E1enzyme
AldesleukinXanthine dehydrogenase/oxidaseenzyme
AldesleukinCytochrome P450 3A4enzyme
AldesleukinCytosolic phospholipase A2enzyme
AldesleukinProstaglandin G/H synthase 2enzyme
AldesleukinCytokine receptor common subunit gammatarget
AldesleukinInterleukin-2 receptor subunit alphatarget
AldesleukinInterleukin-2 receptor subunit betatarget
AlisporivirGuided entry of tail-anchored proteins factor CAMLGtarget
AlisporivirPeptidyl-prolyl cis-trans isomerase Atarget
Alpha-1-proteinase inhibitorNeutrophil elastasetarget
AlsactideAdrenocorticotropic hormone receptortarget
ALT-801MHC class I HLA-A proteintarget
ALT-801Cellular tumor antigen p53target
ALT-801Glucagon receptortarget
ALT-801Glucagon-like peptide 1 receptortarget
ALY688Adiponectin receptortarget
Aminolevulinic acidProtoporphyrinogen oxidasetarget
Aminolevulinic acidSolute carrier family 15 member 2transporter
Aminolevulinic acidSolute carrier family 15 member 1transporter
Aminolevulinic acidDelta-aminolevulinic acid dehydratasetarget
AMY-101Complement C3target
AnakinraInterleukin-1 receptor type 1target
AnamorelinNeutral alpha-glucosidase Ctarget
AnamorelinNeutral alpha-glucosidase ABtarget
AnamorelinLysosomal alpha-glucosidasetarget
AnamorelinGrowth hormone secretagogue receptor type 1target
AncestimMast/stem cell growth factor receptor Kittarget
Angiotensin 1-7Proto-oncogene Mastarget
Angiotensin IIType-1 angiotensin II receptortarget
Angiotensin IIType-2 angiotensin II receptortarget
AngiotensinamideReplicase polyprotein 1abtarget
AngiotensinamideATP-dependent translocase ABCB1transporter
AngiotensinamideType-1 angiotensin II receptortarget
Anidulafungin1,3-beta-glucan synthase component GSC2target
Anidulafungin1,3-beta-glucan synthase component FKS1target
AntipainTryptase alpha/beta-1target
AntipainCathepsin Btarget
AntipainSerine protease 1target
Antithrombin III humanAntithrombin-IIItarget
Anvatabart opadotinReceptor tyrosine-protein kinase erbB-2target
AOD9604Growth hormone receptortarget
AP-102Somatostatin receptor type 2target
AP-102Somatostatin receptor type 5target
ApelinApelin receptortarget
ArgadinEndochitinase B1target
ArgadinChitotriosidase-1target
ArgifinEndochitinase B1target
ArgifinChitotriosidase-1target
Arylomycin A2Signal peptidase Itarget
AspartameOrganic anion transporter 3transporter
AspartameTaste receptor type 1 member 3target
AspartameSolute carrier family 22 member 11transporter
AspartameSolute carrier family 22 member 6transporter
AspartameTransient receptor potential cation channel subfamily V member 1target
AspartameTaste receptor type 1 member 2target
Aspartyl-alanyl-diketopiperazineAlbumincarrier
AstodrimerEnvelope glycoprotein gp160target
AtazanavirCytochrome P450 3A5enzyme
AtazanavirCytochrome P450 3A7enzyme
AtazanavirGag-Pol polyproteintarget
AtazanavirUDP-glucuronosyltransferase 1A1enzyme
AtazanavirSolute carrier organic anion transporter family member 1B1transporter
AtazanavirSolute carrier organic anion transporter family member 1B3transporter
AtazanavirCytochrome P450 2C8enzyme
AtazanavirCytochrome P450 3A4enzyme
AtazanavirPol polyproteintarget
AtazanavirAlbumincarrier
AtazanavirBile salt export pumptransporter
AtazanavirMultidrug resistance-associated protein 1transporter
AtazanavirATP-dependent translocase ABCB1transporter
Atazanaviralpha1-acid glycoproteincarrier
AtazanavirCytochrome P450 1A2enzyme
AtazanavirCytochrome P450 2C9enzyme
AtazanavirSolute carrier organic anion transporter family member 2B1transporter
AtilmotinMotilin receptortarget
ATN-161Fibronectin receptortarget
AtosibanOxytocin receptortarget
AtosibanVasopressin V1a receptortarget
AtosibanVasopressin V1b receptortarget
AtosibanVasopressin V2 receptortarget
Atrial natriuretic peptideNeprilysinenzyme
Atrial natriuretic peptideAtrial natriuretic peptide receptor 3target
Atrial natriuretic peptideAtrial natriuretic peptide receptor 1target
AvexitideGlucagon-like peptide 1 receptortarget
AviptadilVasoactive intestinal polypeptide receptor 1target
AvizafoneAminopeptidase Benzyme
AvoterminTGF-beta receptor type-1target
AvoterminTGF-beta receptor type-2target
Azurin-p28Vascular endothelial growth factor receptor 2target
Azurin-p28Tumor protein p73target
Azurin-p28Tumor protein 63target
Azurin-p28Cellular tumor antigen p53target
BacitracinC55-isoprenyl pyrophosphatetarget
BacitracinBacitracin transport ATP-binding protein BcrAtransporter
BacitracinAlpha-2-macroglobulintarget
BacitracinInsulin-degrading enzymetarget
BacitracinBacitracin transport permease protein BCRBtransporter
BacitracinBacitracin transport permease protein BcrCtransporter
BalixafortideC-X-C chemokine receptor type 4target
BalugrastimGranulocyte colony-stimulating factor receptortarget
BarusibanOxytocin receptortarget
BasifunginInositol phosphorylceramide synthasetarget
BecaplerminPlatelet-derived growth factor receptor alphatarget
BecaplerminAlpha-2-macroglobulintarget
BecaplerminPlatelet-derived growth factor receptor betatarget
BeinaglutideGlucagon-like peptide 1 receptortarget
BelnacasanInterleukin-1 betatarget
BelnacasanCaspase-1target
BempegaldesleukinInterleukin-2 receptor subunit betatarget
BempegaldesleukinInterleukin-2 receptortarget
BI-836858Myeloid cell surface antigen CD33target
BinetrakinInterleukin-4 receptor subunit alphatarget
BirinapantBaculoviral IAP repeat-containing protein 2target
BirinapantE3 ubiquitin-protein ligase XIAPtarget
BivalirudinProthrombintarget
BivalirudinMyeloperoxidaseenzyme
BizaxofuspInterleukin-4 receptor subunit alphatarget
BleomycinBleomycin hydrolaseenzyme
BleomycinDNAtarget
BleomycinDNA ligase 1target
BleomycinDNA ligase 3target
BombesinBombesin receptor subtype-3target
BombesinNeuromedin-B receptortarget
BombesinGastrin-releasing peptide receptortarget
BPC-157Acetylcholinesterasetarget
BQ-123Endothelin-1 receptortarget
BQ-788Endothelin receptor type Btarget
BradykininB2 bradykinin receptortarget
BremelanotideMelanocyte-stimulating hormone receptortarget
BremelanotideMelanocortin receptor 4target
BremelanotideMelanocortin receptor 3target
BremelanotideMelanocortin receptor 5target
BremelanotideAdrenocorticotropic hormone receptortarget
Brentuximab vedotinTumor necrosis factor receptor superfamily member 8target
Brentuximab vedotinCytochrome P450 3A4enzyme
Brentuximab vedotinATP-binding cassette sub-family B member 5transporter
BulevirtideAlbumincarrier
BulevirtideHepatic sodium/bile acid cotransportertarget
BuserelinLutropin-choriogonadotropic hormone receptortarget
BuserelinGonadotropin-releasing hormone receptortarget
BuserelinAromataseenzyme
C326Interleukin-6target
CA-074 methyl esterCathepsin Btarget
CagrilintideCalcitonin receptortarget
Calcitonin gene-related peptideCalcitonin gene-related peptide type 1 receptortarget
CanfosfamideGlutathione S-transferase Ptarget
Caplacizumabvon Willebrand factortarget
Capreomycin16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyAtarget
CarbetocinOxytocin receptortarget
Cardiotrophin 1Interleukin-6 receptor subunit betatarget
CarfilzomibProteasome subunit beta type-1target
CarfilzomibProteasome subunit beta type-2target
CarfilzomibProteasome subunit beta type-10target
CarfilzomibProteasome subunit beta type-9target
CarfilzomibProteasome subunit beta type-5target
CarfilzomibATP-dependent translocase ABCB1transporter
CarfilzomibProteasome subunit beta type-8target
CarnosineSolute carrier family 15 member 1transporter
CarnosineSolute carrier family 15 member 2transporter
CarnosineBeta-Ala-His dipeptidaseenzyme
CarnosineCytosolic non-specific dipeptidaseenzyme
CarnosineCarnosine synthase 1enzyme
CarnosineAngiotensin-converting enzymetarget
CaspofunginSolute carrier family 22 member 1transporter
Caspofungin1,3-beta-glucan synthase component GSC2target
Caspofungin1,3-beta-glucan synthase component FKS1target
CaspofunginCytochrome P450 3A4enzyme
CaspofunginSolute carrier organic anion transporter family member 1B3transporter
CaspofunginSolute carrier organic anion transporter family member 1B1transporter
CaspofunginSolute carrier family 22 member 6transporter
CaspofunginATP-dependent translocase ABCB1transporter
CBP-501MAP kinase-activated protein kinase 2target
CBP-501MAP/microtubule affinity-regulating kinase 3target
CefilavancinPenicillin-binding proteintarget
CemadotinTubulintarget
CenderitideAtrial natriuretic peptide receptor 3target
CenderitideAtrial natriuretic peptide receptor 1target
CenderitideAtrial natriuretic peptide receptor 2target
CenegerminHigh affinity nerve growth factor receptortarget
CenegerminTumor necrosis factor receptor superfamily member 16target
Certolizumab pegolTumor necrosis factortarget
Certolizumab pegolAldo-keto reductase family 1 member A1enzyme
CeruletideCholecystokinin receptor type Atarget
CeruletideGastrin/cholecystokinin type B receptortarget
CetrorelixGonadotropin-releasing hormone receptortarget
CholecystokininSolute carrier organic anion transporter family member 1B1transporter
CholecystokininGastrin/cholecystokinin type B receptortarget
CholecystokininProtein kinase C beta typetarget
CholecystokininPro-epidermal growth factortarget
CholecystokininMitogen-activated protein kinase 3target
CholecystokininRAF proto-oncogene serine/threonine-protein kinasetarget
CholecystokininCholecystokinin receptor type Atarget
CholecystokininSolute carrier organic anion transporter family member 1B3transporter
CholecystokininSolute carrier organic anion transporter family member 2B1transporter
Chorionic Gonadotropin (Human)Lutropin-choriogonadotropic hormone receptortarget
ChymostatinChymasetarget
ChymostatinAmidasetarget
CibinetideErythropoietin receptortarget
CIGB 300Casein kinase II subunit alphatarget
CIGB 300Nucleophosmintarget
Cintredekin besudotoxElongation factor 2target
Cintredekin besudotoxInterleukin-13 receptor subunit alpha-2target
Cintredekin besudotoxInterleukin-13target
CMX-2043RAC-alpha serine/threonine-protein kinasetarget
CMX-2043Hepatocyte growth factor receptortarget
ColistimethateDihydropteroate synthasetarget
ColistimethateBacterial outer membranetarget
ColistinDihydropteroate synthasetarget
ColistinBacterial outer membranetarget
Conestat alfaProthrombintarget
Conestat alfaCoagulation factor XIItarget
Conestat alfaPlasma kallikreintarget
Conestat alfaComplement C1s subcomponenttarget
Conestat alfaTissue-type plasminogen activatortarget
Conestat alfaCoagulation factor XItarget
Conestat alfaPlasma protease C1 inhibitortarget
Conestat alfaComplement C1r subcomponenttarget
Contulakin-GNeurotensin receptor type 1target
Contulakin-GVoltage-dependent N-type calcium channel subunit alpha-1Btarget
Copper oxodotreotide Cu-64Somatostatin receptor type 2target
CorticorelinCorticotropin-releasing hormone receptor 2target
CorticorelinDopamine beta-hydroxylaseenzyme
CorticorelinCorticotropin-releasing hormone receptor 1target
Corticorelin ovine triflutateCorticotropin-releasing hormone receptor 2target
Corticorelin ovine triflutateCorticotropin-releasing hormone receptor 1target
Corticotropin3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2enzyme
CorticotropinAdrenocorticotropic hormone receptortarget
CorticotropinCorticotropin-releasing hormonetarget
Corticotropin25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrialenzyme
Corticotropin1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrialenzyme
CorticotropinCytochrome P450 3A4enzyme
CR665Kappa-type opioid receptortarget
CTCE-0214Stromal cell-derived factor 1target
Cyclo(his-pro)Chitinase Btarget
Cyclo(prolylglycyl)Chitinase Btarget
CyclosporineProtein phosphatase 3 catalytic subunit alphatarget
CyclosporineSolute carrier organic anion transporter family member 1B3transporter
CyclosporineSolute carrier organic anion transporter family member 1B1transporter
CyclosporinePeptidyl-prolyl cis-trans isomerase F, mitochondrialtarget
CyclosporineCytochrome P450 2D6enzyme
CyclosporineCalcineurin subunit B type 2target
CyclosporineGuided entry of tail-anchored proteins factor CAMLGtarget
CyclosporinePeptidyl-prolyl cis-trans isomerase Atarget
CyclosporineCytochrome P450 2C19enzyme
CyclosporineCytochrome P450 3A5enzyme
CyclosporineCytochrome P450 3A4enzyme
CyclosporineATP-dependent translocase ABCB1transporter
CyclosporineBile salt export pumptransporter
CyclosporineIleal sodium/bile acid cotransportertransporter
CyclosporineHepatic sodium/bile acid cotransportertransporter
CyclosporineSolute carrier family 22 member 6transporter
CyclosporineATP-binding cassette sub-family C member 10transporter
CyclosporineATP-binding cassette sub-family C member 2transporter
CyclosporineBroad substrate specificity ATP-binding cassette transporter ABCG2transporter
Cyclotheonamide ASerine protease 1target
CYT006-AngQbType-2 angiotensin II receptortarget
CYT006-AngQbType-1 angiotensin II receptortarget
DactinomycinDNA topoisomerase 1target
DactinomycinDNA topoisomerase 2target
DactinomycinBroad substrate specificity ATP-binding cassette transporter ABCG2transporter
DactinomycinMultidrug resistance-associated protein 1transporter
DactinomycinATP-binding cassette sub-family C member 6transporter
DactinomycinATP-dependent translocase ABCB1transporter
DactinomycinOrganic cation/carnitine transporter 2transporter
DactinomycinDNAtarget
DADLEMu-type opioid receptortarget
DADLEDelta-type opioid receptortarget
DADLESolute carrier organic anion transporter family member 1B1transporter
DalanterceptGrowth/differentiation factor 2target
DalanterceptBone morphogenetic protein 10target
DalbavancinD-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycantarget
DalbavancinPancreatic triacylglycerol lipasetarget
DalfopristinStreptogramin A acetyltransferasetarget
DalfopristinCytochrome P450 3A4enzyme
DalfopristinBacterial 50S ribosomal proteintarget
DanegaptideGap junction alpha-1 proteintarget
DapiclerminAcetyl-CoA carboxylase 2target
Dapirolizumab pegolCD40 ligandtarget
DaptomycinDihydropteroate synthasetarget
DaptomycinATP-dependent translocase ABCB1transporter
DaptomycinHemopexincarrier
DaptomycinSex hormone-binding globulincarrier
DaptomycinLow-density lipoprotein receptorcarrier
DaptomycinAlpha-1-antitrypsincarrier
DaptomycinAlpha-1-acid glycoprotein 1carrier
DaptomycinAlbumincarrier
DaptomycinCytoplasmic membranetarget
DarinaparsinTubulintarget
DasiglucagonGlucagon receptortarget
DavunetideTubulintarget
DavunetideGlycogen synthase kinase-3 betatarget
DavunetideGlycogen synthase kinase-3 alphatarget
DegarelixGonadotropin-releasing hormone receptortarget
Denileukin diftitoxInterleukin-2 receptor subunit alphatarget
Denileukin diftitoxInterleukin-2 receptor subunit betatarget
Denileukin diftitoxElongation factor 2target
DepreotideSomatostatin receptor type 5target
DepreotideSomatostatin receptor type 3target
DepreotideSomatostatin receptor type 2target
DesirudinCarboxypeptidase A1enzyme
DesirudinProthrombintarget
DeslorelinGonadotropin-releasing hormone receptortarget
DesmopressinOxytocin receptortarget
DesmopressinProstaglandin G/H synthase 2enzyme
DesmopressinProstaglandin G/H synthase 1enzyme
DesmopressinVasopressin V2 receptortarget
DesmopressinVasopressin V1a receptortarget
DesmopressinVasopressin V1b receptortarget
DetirelixGonadotropin-releasing hormone receptortarget
DiaPep 27760 kDa heat shock protein, mitochondrialtarget
Dibotermin alfaBone morphogenetic protein receptor type-1Atarget
Dibotermin alfaBone morphogenetic protein receptor type-2target
Dibotermin alfaActivin receptor type-2Btarget
Dibotermin alfaBone morphogenetic protein receptor type-1Btarget
Dibotermin alfaActivin receptor type-2Atarget
Dibotermin alfaActivin receptor type-1target
Disitamab vedotinReceptor tyrosine-protein kinase erbB-2target
DitekirenBile salt export pumptransporter
DitekirenATP-dependent translocase ABCB1transporter
DitekirenRenintarget
Dolastatin 10Tubulin beta-2A chaintarget
DopastatinD(2) dopamine receptortarget
DopastatinSomatostatin receptor type 2target
DopastatinSomatostatin receptor type 5target
DopastatinPolyunsaturated fatty acid 5-lipoxygenasetarget
Dotatate gallium Ga-68Somatostatin receptor type 2target
DPDPEKappa-type opioid receptortarget
DPDPESolute carrier organic anion transporter family member 1B3transporter
DPDPEMu-type opioid receptortarget
DPDPEDelta-type opioid receptortarget
DulaglutideGlucagon-like peptide 1 receptortarget
DulanerminTumor necrosis factor receptor superfamily member 10Btarget
DulanerminTumor necrosis factor receptor superfamily member 10Atarget
DusquetideSequestosome-1target
DynorphinMu-type opioid receptortarget
DynorphinDelta-type opioid receptortarget
DynorphinKappa-type opioid receptortarget
EchinomycinHypoxia-inducible factor 1target
EchinomycinHypoxia-inducible factor 1-alphatarget
EDI-200Tumor necrosis factor receptor superfamily member EDARtarget
Edodekin alfaInterleukin-12 receptor subunit beta-2target
Edodekin alfaInterleukin-12 receptor subunit beta-1target
EdotreotideSomatostatin receptor type 2target
EdotreotideSomatostatin receptor type 5target
EdotreotideSomatostatin receptortarget
Edotreotide yttrium Y-90Somatostatin receptortarget
Efbemalenograstim alfaGranulocyte colony-stimulating factortarget
Efbemalenograstim alfaGranulocyte colony-stimulating factor receptortarget
EfegatranProthrombintarget
Efineptakin alfaInterleukin-7 receptor subunit alphatarget
EflapegrastimGranulocyte colony-stimulating factor receptortarget
Eflepedocokin alfaInterleukin-22 receptor subunit alpha-1target
EfruxiferminBeta-klothotarget
Eftrenonacog alfaCoagulation factor IXtarget
Eftrenonacog alfaIgG receptor FcRn large subunit p51target
EGEN-001Interleukin-12 receptor subunit beta-1target
EGEN-001Interleukin-12 receptor subunit beta-2target
ElafinNeutrophil elastasetarget
ElafinMyeloblastintarget
ElafinMyeloperoxidaseenzyme
ElamipretideCardiolipintarget
ElamipretideMultidrug and toxin extrusion protein 1transporter
ElisidepsinReceptor tyrosine-protein kinase erbB-3target
ElobixibatIleal sodium/bile acid cotransportertarget
EmfilerminLeukemia inhibitory factor receptortarget
EmfilerminInterleukin-6 receptor subunit betatarget
EnalaprilAngiotensin-converting enzymetarget
EnalaprilATP-dependent translocase ABCB1transporter
EnalaprilSolute carrier family 15 member 1transporter
EnalaprilSolute carrier family 22 member 6transporter
EnalaprilOrganic anion transporter 3transporter
EnalaprilSolute carrier family 22 member 7transporter
EnalaprilSolute carrier organic anion transporter family member 1A2transporter
EnalaprilAlbumincarrier
EnalaprilatB1 bradykinin receptortarget
EnalaprilatAngiotensin-converting enzymetarget
EnalkirenRenintarget
EnarodustatEgl nine homolog 1target
EndostatinAromataseenzyme
EndostatinE-selectintarget
EndostatinFocal adhesion kinase 1target
EndostatinCollagenase 3target
EndostatinProlactin receptortarget
Endostatin72 kDa type IV collagenasetarget
EndostatinMatrix metalloproteinase-9target
Endothelin-1Endothelin-1 receptortarget
Endothelin-1Endothelin receptor type Btarget
EnfuvirtideCytochrome P450 2E1enzyme
EnfuvirtideCytochrome P450 2C19enzyme
EnfuvirtideEnv polyproteintarget
EpitalonTelomerase reverse transcriptasetarget
Epoetin betaErythropoietin receptortarget
Epoetin deltaErythropoietin receptortarget
EptifibatideIntegrin alpha-IIbtarget
EptifibatideVoltage-dependent N-type calcium channeltarget
EptifibatideIntegrin beta-3target
Eptotermin alfaBone morphogenetic protein receptor type-1Atarget
Eptotermin alfaBone morphogenetic protein receptor type-2target
Eptotermin alfaBone morphogenetic protein receptor type-1Btarget
Eptotermin alfaActivin receptor type-1target
ErythropoietinErythropoietin receptortarget
EtanerceptLow affinity immunoglobulin gamma Fc region receptor II-atarget
EtanerceptComplement component 1q (C1q)target
EtanerceptLow affinity immunoglobulin gamma Fc region receptor II-ctarget
EtanerceptTumor necrosis factortarget
EtanerceptLymphotoxin-alphatarget
EtanerceptLow affinity immunoglobulin gamma Fc region receptor III-Btarget
EtanerceptLow affinity immunoglobulin gamma Fc region receptor III-Atarget
EtanerceptHigh affinity immunoglobulin gamma Fc receptor Itarget
EtanerceptLow affinity immunoglobulin gamma Fc region receptor II-btarget
EvorpaceptLeukocyte surface antigen CD47target
ExamorelinGrowth hormone-releasing hormone receptortarget
ExenatideDipeptidyl peptidase 4enzyme
ExenatideAlbumincarrier
ExenatideGlucagon-like peptide 1 receptortarget
EzatiostatGlutathione S-transferase Ptarget
FelypressinVasopressin V1a receptortarget
FilgrastimNeutrophil elastaseenzyme
FilgrastimGranulocyte colony-stimulating factor receptortarget
FlovagatranProthrombintarget
FollitropinFollicle-stimulating hormone receptortarget
GallichromeIron(3+)-hydroxamate-binding protein FhuDtarget
gamma-GlutamylcysteineGlutathione synthetasetarget
GancotamabReceptor tyrosine-protein kinase erbB-2target
GancotamabDNA topoisomerase 2-alphatarget
GanirelixGonadotropin-releasing hormone receptortarget
Gastric inhibitory polypeptideGastric inhibitory polypeptide receptortarget
GB-115Gastrin/cholecystokinin type B receptortarget
GE-2270AElongation factor Tutarget
GE-2270AElongation factor 1-alphatarget
GlatiramerMHC class II protein complextarget
GLP-1 (7-36) amideGlucagon-like peptide 1 receptortarget
GLP-1 (7-36) amideDipeptidyl peptidase 4enzyme
GlucagonGlucagon-like peptide 1 receptortarget
GlucagonGlucagon-like peptide 2 receptortarget
GlucagonGlucagon receptortarget
GlutathioneGlutathione S-transferase Mu 2target
GlutathioneGlutathione S-transferase A1target
GlutathioneGlutathione S-transferase A3target
GlutathioneGlutathione S-transferase kappa 1target
GlutathioneGlutathione S-transferase Mu 1target
GlutathioneGlutathione synthetasetarget
GlutathioneGlutathione reductase, mitochondrialtarget
GlutathioneGlutathione S-transferase A2enzyme
GlutathioneHydroxyacylglutathione hydrolase, mitochondrialtarget
GlutathioneGlutathione peroxidase 6target
GlutathioneGlutathione S-transferase Mu 5target
GlutathionePhospholipid hydroperoxide glutathione peroxidase GPX4target
GlutathioneGlutaredoxin-1target
GlutathioneGlutaredoxin-2, mitochondrialtarget
GlutathioneGlutathione hydrolase 1 proenzymetarget
GlutathioneS-formylglutathione hydrolasetarget
GlutathioneMicrosomal glutathione S-transferase 1target
GlutathioneGlutathione S-transferase A2target
GlutathioneGlutathione S-transferase omega-2target
GlutathioneGlutathione S-transferase A4target
GlutathioneGlutathione S-transferase Mu 4target
GlutathioneGlutathione S-transferase A5target
GlutathioneGlutathione peroxidasetarget
GlutathioneProtein peroxidase GPX7target
GlutathioneGlutathione S-transferase Ptarget
GlutathioneGlutathione S-transferase omega-1target
GlutathioneGlutathione peroxidase 1target
GlutathioneGlutathione S-transferase Mu 3target
GlutathioneHematopoietic prostaglandin D synthasetarget
GlutathioneGlutathione S-transferase 3, mitochondrialtarget
GlutathioneLeukotriene C4 synthasetarget
GlutathioneLactoylglutathione lyasetarget
GlutathioneGlutathione peroxidase 3target
GlutathioneEpididymal secretory glutathione peroxidasetarget
GlutathioneMaleylacetoacetate isomerasetarget
GlutathioneMicrosomal glutathione S-transferase 2target
GlutathioneGlutathione S-transferase theta-1target
GlutathioneGlutathione peroxidase 2target
GlutathioneATP-binding cassette sub-family C member 3transporter
GlutathioneATP-binding cassette sub-family C member 2transporter
GlutathioneInosine-5'-monophosphate dehydrogenase 1target
GlutathioneGlutathione peroxidasetarget
GlutathioneCytochrome P450 3A4target
GlutathioneMatrix metalloproteinase-9target
GlutathioneAldo-keto reductase family 1 member B1target
GlutathioneATP-binding cassette sub-family C member 5transporter
GlutathioneATP-binding cassette sub-family C member 4transporter
GlutathioneMultidrug resistance-associated protein 1transporter
GlutathioneGlutathione S-transferase A1enzyme
Glutathione disulfideGlutathione S-transferases (Cytosolic)target
Glutathione disulfideMicrosomal glutathione S-transferase 1target
Glutathione disulfideGlutathione peroxidasetarget
Glutathione disulfideGlutathione reductase, mitochondrialtarget
Glutathione disulfideGlutathione S-transferase Mu 2target
GlycylglutamineSolute carrier family 15 member 2transporter
GlycylglutamineSolute carrier family 15 member 1transporter
GlyphosateAlbumincarrier
GlyphosateAromatasetarget
Glyphosate3-phosphoshikimate 1-carboxyvinyltransferasetarget
Glyphosate3-phosphoshikimate 1-carboxyvinyltransferasetarget
GlypromateNMDA receptortarget
GolotimodToll-like receptor 2target
GolotimodSignal transducer and activator of transcription 3target
GolotimodToll-like receptor 9target
GolotimodToll-like receptor 7target
GolotimodToll-like receptor 4target
GonadorelinPutative gonadotropin-releasing hormone II receptortarget
GonadorelinGonadotropin-releasing hormone receptortarget
GontivimabFusion glycoprotein F0target
Gonyautoxin IISodium channel proteintarget
GoralatideAngiotensin-converting enzymeenzyme
GoserelinLutropin-choriogonadotropic hormone receptortarget
GoserelinGonadotropin-releasing hormone receptortarget
GoserelinProgonadoliberin-1target
Gramicidin DATP-dependent translocase ABCB1transporter
Gramicidin DDihydropteroate synthasetarget
GS-9256Gag-Pol polyproteintarget
GsMtx-4Short transient receptor potential channel 6target
GsMtx-4Short transient receptor potential channel 1target
GsMtx-4Piezo-type mechanosensitive ion channel component 1target
Hexapeptide-2Growth hormone receptortarget
HiltonolToll-like receptor 3target
HistrelinGonadotropin-releasing hormone receptortarget
Human C1-esterase inhibitorTissue-type plasminogen activatortarget
Human C1-esterase inhibitorCoagulation factor XItarget
Human C1-esterase inhibitorProthrombintarget
Human C1-esterase inhibitorCoagulation factor XIItarget
Human C1-esterase inhibitorPlasma kallikreintarget
Human C1-esterase inhibitorComplement C1s subcomponenttarget
Human C1-esterase inhibitorComplement C1r subcomponenttarget
Human interferon betaCytochrome P450 1A2enzyme
Human interferon betaInterferon alpha/beta receptor 1target
Human interferon betaAlbumincarrier
Human Interleukin 8C-X-C chemokine receptor type 4target
Human Interleukin 8C-X-C chemokine receptor type 2target
Human Interleukin 8Interleukin-8target
Human interleukin-2Interleukin-2 receptortarget
Human interleukin-2Interleukin-2 receptor subunit alphatarget
Human interleukin-6Interleukin-6 receptor subunit alphatarget
IbodutantSubstance-K receptortarget
IcatibantB2 bradykinin receptortarget
IcatibantAminopeptidase Ntarget
IcotrokinraInterleukin-23 receptortarget
IlomastatDisintegrin and metalloproteinase domain-containing protein 28target
Ilomastat72 kDa type IV collagenasetarget
IlomastatStromelysin-1target
IlomastatMatrix metalloproteinase-9target
IlomastatLethal factortarget
IlomastatMacrophage metalloelastasetarget
IlomastatCollagenase 3target
IlomastatAggrecan core proteintarget
IlomastatInterstitial collagenasetarget
IlomastatNeutrophil collagenasetarget
IlomastatMatrix metalloproteinase-14target
Indium In-111 pentetreotideSomatostatin receptortarget
Indium In-111 pentetreotideSomatostatin receptor type 2target
Indium In-111 satumomab pendetideTumor-associated glycoprotein 72 (TAG-72)target
Insulin aspartInsulin receptortarget
Insulin aspartInsulin-like growth factor 1 receptortarget
Insulin aspartCytochrome P450 1A2enzyme
Insulin aspartInsulintarget
Insulin degludecAlbumincarrier
Insulin degludecInsulin-like growth factor 1 receptortarget
Insulin degludecInsulin receptortarget
Insulin degludecCytochrome P450 1A2enzyme
Insulin degludecInsulin-degrading enzymeenzyme
Insulin degludecInsulintarget
Insulin detemirAlbumincarrier
Insulin detemirInsulin-like growth factor 1 receptortarget
Insulin detemirCytochrome P450 1A2enzyme
Insulin detemirInsulin-degrading enzymeenzyme
Insulin detemirInsulintarget
Insulin detemirInsulin receptortarget
Insulin glargineCytochrome P450 1A2enzyme
Insulin glargineInsulintarget
Insulin glargineInsulin-like growth factor 1 receptortarget
Insulin glargineInsulin receptortarget
Insulin glulisineInsulin receptortarget
Insulin glulisineInsulin-like growth factor 1 receptortarget
Insulin glulisineCytochrome P450 1A2enzyme
Insulin humanInsulin receptortarget
Insulin humanInsulin-like growth factor 1 receptortarget
Insulin humanInsulin-like growth factor-binding protein 7target
Insulin humanInsulin-degrading enzymeenzyme
Insulin humanNeuroendocrine convertase 2enzyme
Insulin humanNeuroendocrine convertase 1enzyme
Insulin humanCytochrome P450 1A2enzyme
Insulin humanCarboxypeptidase Etarget
Insulin humanCCN family member 3target
Insulin humanLow-density lipoprotein receptor-related protein 2target
Insulin icodecAlbumincarrier
Insulin icodecInsulin-like growth factor 1 receptortarget
Insulin icodecInsulin receptortarget
Insulin icodecInsulin-degrading enzymeenzyme
Insulin lisproInsulin-degrading enzymeenzyme
Insulin lisproCytochrome P450 1A2enzyme
Insulin lisproInsulin-like growth factor 1 receptortarget
Insulin lisproInsulin receptortarget
Insulin peglisproInsulintarget
Insulin peglisproInsulin-like growth factor 1 receptortarget
Insulin peglisproInsulin receptortarget
Insulin peglisproCytochrome P450 1A2enzyme
Insulin porkInsulin-degrading enzymeenzyme
Insulin porkInsulin-like growth factor 1 receptortarget
Insulin porkCytochrome P450 1A2enzyme
Insulin porkInsulin receptortarget
Interferon alfaInterferon alpha/beta receptor 1target
Interferon alfaCytochrome P450 1A2enzyme
Interferon alfa-1bInterferon alpha/beta receptor (IFNAR)target
Interferon alfa-2aCytochrome P450 1A2enzyme
Interferon alfa-2aInterferon alpha/beta receptor 2target
Interferon alfa-2aInterferon alpha/beta receptor 1target
Interferon alfa-2bInterferon alpha-2target
Interferon alfa-2bCytochrome P450 1A2enzyme
Interferon alfa-2bInterferon alpha/beta receptor 1target
Interferon alfa-2bInterferon alpha/beta receptor 2target
Interferon alfa-2cCytochrome P450 1A2enzyme
Interferon alfa-2cInterferon alpha/beta receptor (IFNAR)target
Interferon alfa-n1Interferon alpha/beta receptor 2target
Interferon alfa-n1Cytochrome P450 1A2enzyme
Interferon alfa-n1Interferon alpha/beta receptor 1target
Interferon alfa-n3Cytochrome P450 1A2enzyme
Interferon alfa-n3Interferon alpha/beta receptor 2target
Interferon alfa-n3Interferon alpha/beta receptor 1target
Interferon alfacon-1Interferon alpha/beta receptor 2target
Interferon alfacon-1Interferon alpha/beta receptor 1target
Interferon alfacon-1Cytochrome P450 1A2enzyme
Interferon beta-1aInterferon alpha/beta receptor 1target
Interferon beta-1aInterferon alpha/beta receptor 2target
Interferon beta-1aCytochrome P450 1A2enzyme
Interferon beta-1aInterferon betatarget
Interferon beta-1bCytochrome P450 1A2enzyme
Interferon beta-1bInterferon alpha/beta receptor 2target
Interferon beta-1bInterferon alpha/beta receptor 1target
Interferon gamma-1bCytochrome P450 1A2enzyme
Interferon gamma-1bInterferon gamma receptor 2target
Interferon gamma-1bInterferon gamma receptor 1target
Interleukin-1 alpha, human recombinantInterleukin-1 alphatarget
Interleukin-10Interleukin-10 receptor subunit betatarget
Interleukin-10Interleukin-10 receptor subunit alphatarget
Interleukin-15, human recombinantInterleukin-15 receptor subunit alphatarget
Interleukin-7Interleukin-7 receptor subunit alphatarget
IpafriceptFrizzled-8target
IpamorelinGrowth hormone secretagogue receptor type 1target
ISF402Insulintarget
Isospaglumic acidMetabotropic glutamate receptor 3target
IturelixGonadotropin-releasing hormone receptortarget
JE-2147Gag-Pol polyproteintarget
JE-2147Gag-Pol polyproteintarget
KelatorphanGlutamyl aminopeptidasetarget
KelatorphanAminopeptidase Ntarget
KelatorphanLeukotriene A-4 hydrolasetarget
KisspeptinKiSS-1 receptortarget
Kisspeptin-10KiSS-1 receptortarget
LabradimilB2 bradykinin receptortarget
LampalizumabComplement factor Dtarget
LancovutideCytosolic phospholipase A2enzyme
LancovutideAnoctamin-1target
LancovutideV-ATPase Subunitstarget
LanreotideCytochrome P450 3A4enzyme
LanreotideSomatostatin receptor type 5target
LanreotideSomatostatin receptor type 2target
LarazotideHaptoglobintarget
LenograstimGranulocyte colony-stimulating factor receptortarget
LenomorelinGrowth hormone secretagogue receptor type 1target
LepirudinProthrombintarget
LeptinLeptin receptortarget
LeridistimGranulocyte colony-stimulating factor receptortarget
LeridistimInterleukin-3 receptor subunit alphatarget
LeupeptinPlasmepsin IItarget
LeuprolideGonadotropin-releasing hormone receptortarget
LeuprolideProgonadoliberin-1target
LipegfilgrastimGranulocyte colony-stimulating factor receptortarget
LiraglutideGlucagon-like peptide 1 receptortarget
LiraglutideDipeptidyl peptidase 4enzyme
LiraglutideNeprilysinenzyme
LiraglutideAlbumincarrier
LisinoprilSolute carrier family 15 member 2transporter
LisinoprilAngiotensin-converting enzymetarget
LisinoprilRenintarget
LisinoprilSolute carrier family 15 member 1transporter
LivoletideGrowth hormone secretagogue receptor type 1target
LonapegsomatropinCytochrome P450 1A2enzyme
LonapegsomatropinProlactin receptortarget
LonapegsomatropinCytochrome P450 2C19enzyme
LonapegsomatropinGrowth hormone receptortarget
Lonapegsomatropin11-beta-hydroxysteroid dehydrogenase 1enzyme
LonapegsomatropinATP-dependent translocase ABCB1transporter
Lorukafusp alfaGD2 disialogangliosidetarget
LTX-109Cytoplasmic membranetarget
LuspaterceptGrowth/differentiation factor 11target
LuspaterceptInhibin beta B chaintarget
Luteinizing hormoneLutropin-choriogonadotropic hormone receptortarget
Lutetium Lu 177 dotatateSomatostatin receptor type 2target
Lutetium Lu 177 dotatateSomatostatin receptor type 1target
Lutetium Lu 177 dotatateSomatostatin receptor type 3target
Lutetium Lu 177 dotatateSomatostatin receptor type 4target
Lutetium Lu 177 dotatateSomatostatin receptor type 5target
Lutetium Lu 177 dotatateSomatostatin receptortarget
Lutetium Lu177 EdotreotideSomatostatin receptor type 2target
Lutetium Lu177 EdotreotideSomatostatin receptor type 5target
Lutetium Lu177 EdotreotideSomatostatin receptortarget
LypressinVasopressin V1a receptortarget
LypressinVasopressin V2 receptortarget
LypressinVasopressin V1b receptortarget
LypressinATP-binding cassette sub-family C member 2transporter
Malacidin ANAM/NAG peptide subunits of peptidoglycantarget
Malacidin BNAM/NAG peptide subunits of peptidoglycantarget
MALP-2Toll-like receptor 6target
MALP-2Toll-like receptor 2target
Mdl 101,146Neutrophil elastasetarget
Mdl 101,146Chymotrypsin-like elastase family member 1target
MecapegfilgrastimGranulocyte colony-stimulating factor receptortarget
MecaserminInsulin-like growth factor-binding protein 6carrier
MecaserminInsulin-like growth factor-binding protein 5carrier
MecaserminInsulin-like growth factor 1target
MecaserminInsulin-like growth factor 1 receptortarget
MecaserminInsulin-like growth factor-binding protein 3target
MecaserminInsulin receptortarget
MecaserminCation-independent mannose-6-phosphate receptortarget
MecaserminInsulin-like growth factor-binding protein 3carrier
MecaserminInsulin-like growth factor-binding protein complex acid labile subunitcarrier
MecaserminInsulin-like growth factor-binding protein 1carrier
MecaserminInsulin-like growth factor-binding protein 2carrier
MecaserminInsulin-like growth factor-binding protein 4carrier
MenotropinsLutropin-choriogonadotropic hormone receptortarget
MenotropinsFollicle-stimulating hormone receptortarget
MetenkefalinOpioid growth factor receptortarget
MetenkefalinMu-type opioid receptortarget
MetenkefalinDelta-type opioid receptortarget
MetenkefalinCarboxypeptidase A6enzyme
Methoxy polyethylene glycol-epoetin betaErythropoietin receptortarget
MetkephamidDelta-type opioid receptortarget
MetreleptinLeptin receptortarget
Micafungin1,3-beta-glucan synthase component FKS1target
MicafunginCatechol O-methyltransferaseenzyme
MicafunginArylsulfatase Aenzyme
Micafungin1,3-beta-glucan synthase component GSC2target
MifamurtideNucleotide-binding oligomerization domain-containing protein 2target
MifamurtideToll-like receptor 4target
MinigastrinGastrin/cholecystokinin type B receptortarget
MM3122Transmembrane protease serine 2target
MolgramostimGranulocyte-macrophage colony-stimulating factor receptor subunit alphatarget
MolgramostimCytokine receptor common subunit betatarget
MontirelinThyrotropin-releasing hormone receptortarget
MotixafortideC-X-C chemokine receptor type 4target
MotuporinSerine/threonine-protein phosphatase PP1-gamma catalytic subunittarget
MuplestimInterleukin-3 receptor subunit alphatarget
MurabutideNucleotide-binding oligomerization domain-containing protein 2target
N-(1-carboxy-3-phenylpropyl)phenylalanyl-alpha-asparagineElastasetarget
N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-ProlineCathepsin Btarget
N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanineD-alanyl-D-alanine carboxypeptidasetarget
NafarelinGonadotropin-releasing hormone receptortarget
NafarelinPutative gonadotropin-releasing hormone II receptortarget
NagrestipenHeat shock 70 kDa protein 1Atarget
NagrestipenHigh mobility group protein B1target
NagrestipenC-C chemokine receptor type 5target
NagrestipenC-C chemokine receptor type 1target
NangibotideTriggering receptor expressed on myeloid cells 1target
NavepegritideAtrial natriuretic peptide receptor 2target
Neladenoson bialanateAdenosine receptor A1target
Nelipepimut-SReceptor tyrosine-protein kinase erbB-2target
Nelipepimut-SHLA class I histocompatibility antigen, A alpha chaintarget
NepadutantSubstance-K receptortarget
NepiderminEpidermal growth factor receptortarget
NerinetideDisks large homolog 4target
Nerve Growth FactorTumor necrosis factor receptor superfamily member 16target
Nerve Growth FactorHigh affinity nerve growth factor receptortarget
NesiritideAtrial natriuretic peptide receptor 3target
NesiritideAtrial natriuretic peptide receptor 2target
NesiritideAtrial natriuretic peptide receptor 1target
Neuropeptide YNeuropeptide Y receptor type 2target
Neuropeptide YNeuropeptide Y receptor type 1target
Nitrilotriacetic acidLactotransferrintarget
NN344Insulin receptortarget
NN344Cytochrome P450 1A2enzyme
Nogapendekin alfaInterleukin-2 receptor subunit betatarget
Nogapendekin alfaCytokine receptor common subunit gammatarget
Nona-arginineNitric oxide synthase, inducibletarget
NOV-002Protein disulfide-isomerasetarget
NOV-002Glutathione reductase, mitochondrialenzyme
OBP-801Histone deacetylase 1target
OcriplasminAlpha-2-macroglobulintarget
OcriplasminAlpha-2-antiplasmintarget
OcriplasminFibronectintarget
OctreotideSomatostatin receptortarget
OctreotideMyeloperoxidaseenzyme
OctreotideCytochrome P450 3A4enzyme
OctreotideAlbumincarrier
OctreotideATP-dependent translocase ABCB1transporter
OctreotideSomatostatin receptortarget
OctreotideSomatostatin receptor type 2target
OctreotideATP-binding cassette sub-family C member 2transporter
OlcegepantCalcitonin gene-related peptide 1target
OlcegepantCalcitonin gene-related peptide type 1 receptortarget
OmberacetamEgl nine homolog 1target
OprelvekinInterleukin-11 receptor subunit alphatarget
OprozomibProteasome subunit beta type-5target
OritavancinCytochrome P450 2C19enzyme
OritavancinPentaglycyl bridging segmenttarget
OritavancinCytochrome P450 3A4enzyme
OritavancinCytochrome P450 2D6enzyme
OritavancinCytochrome P450 2C9enzyme
OritavancinAlbumincarrier
OritavancinPeptidoglycan precursorstarget
OritavancinBacterial cell wall peptide bridging segmentstarget
OritavancinDihydropteroate synthasetarget
OrnipressinVasopressin V1a receptortarget
OrnithineOrnithine aminotransferase, mitochondrialtarget
OrnithineOrnithine transcarbamylase, mitochondrialtarget
OrnithineArginase-1target
OrnithineOrnithine decarboxylase antizyme 1target
OrnithineCationic amino acid transporter 2target
OrnithineMitochondrial ornithine transporter 2target
OrnithineHigh affinity cationic amino acid transporter 1target
OrnithineArginase-2, mitochondrialtarget
OrnithineMitochondrial ornithine transporter 1target
OrnithineGlycine amidinotransferase, mitochondrialtarget
Ostabolin-CParathyroid hormone/parathyroid hormone-related peptide receptortarget
OxeclosporinCytochrome P450 3A Subfamilyenzyme
OxeclosporinCytochrome P450 3A4enzyme
OxytocinOxytocin receptortarget
OxytocinProlyl endopeptidaseenzyme
OxytocinVasopressin V2 receptortarget
OxytocinOxytocin-neurophysin 1 proproteincarrier
OxytocinLeucyl-cystinyl aminopeptidaseenzyme
OxytocinVasopressin V1b receptortarget
OxytocinAdvanced glycation end product-specific receptortransporter
OxytocinVasopressin V1a receptortarget
OzarelixGonadotropin-releasing hormone receptortarget
PaliferminBasement membrane-specific heparan sulfate proteoglycan core proteintarget
PaliferminFibroblast growth factor receptor 1target
PaliferminFibroblast growth factor receptor 2target
PalopegteriparatideParathyroid hormone/parathyroid hormone-related peptide receptortarget
Pam2csk4Toll-like receptor 6target
Pam2csk4Toll-like receptor 2target
Pancreatic PolypeptideNeuropeptide Y receptor type 4-2target
Pancreatic PolypeptideNeuropeptide Y receptor type 4target
Parathyroid hormoneParathyroid hormone/parathyroid hormone-related peptide receptortarget
Parathyroid hormoneParathyroid hormone 2 receptortarget
PasireotideCytochrome P450 3A4enzyme
PasireotideSomatostatin receptor type 5target
PasireotideSomatostatin receptor type 3target
PasireotideSomatostatin receptor type 2target
PasireotideSomatostatin receptor type 1target
PegbelferminBeta-klothotarget
PegbelferminFibroblast growth factor receptor 1target
PegcetacoplanComplement C3target
PegdinetanibVascular endothelial growth factor receptor 2target
PegfilgrastimNeutrophil elastaseenzyme
PegfilgrastimGranulocyte colony-stimulating factor receptortarget
PegilodecakinInterleukin-10 receptor subunit alphatarget
PegilodecakinInterleukin-10 receptor subunit betatarget
Peginterferon alfa-2aInterferon alpha/beta receptor 2target
Peginterferon alfa-2aInterferon alpha/beta receptor 1target
Peginterferon alfa-2aCytochrome P450 1A2enzyme
Peginterferon alfa-2aInterferon alpha-2target
Peginterferon alfa-2bInterferon alpha/beta receptor 1target
Peginterferon alfa-2bInterferon alpha/beta receptor 2target
Peginterferon alfa-2bCytochrome P450 1A2enzyme
Peginterferon alfa-2bCytochrome P450 2D6enzyme
Peginterferon alfa-2bCytochrome P450 2C9enzyme
Peginterferon alfa-2bInterferon alpha-2target
Peginterferon beta-1aInterferon alpha/beta receptor 1target
Peginterferon beta-1aCytochrome P450 1A2enzyme
Peginterferon lambda-1aInterferon lambda receptor 1target
PegmusirudinProthrombintarget
PegvisomantGrowth hormone receptortarget
PegvisomantSterol 26-hydroxylase, mitochondrialenzyme
PegvisomantGlutamine synthetaseenzyme
PegvisomantCytochrome P450 3A4enzyme
PegvisomantCholinesteraseenzyme
PegvisomantCytochrome P450 4A11enzyme
PentagastrinGastrin/cholecystokinin type B receptortarget
PentagastrinCholinesteraseenzyme
PentetreotideSomatostatin receptor type 2target
PentetreotideSomatostatin receptor type 5target
PentetreotideSomatostatin receptortarget
PepstatinPlasmepsin IItarget
Peptide YY (1-36)Neuropeptide Y receptor type 5target
Peptide YY (1-36)Dipeptidyl peptidase 4enzyme
Peptide YY (1-36)Neuropeptide Y receptor type 2target
Peptide YY (1-36)Xaa-Pro aminopeptidase 1enzyme
Peptide YY (1-36)Neuropeptide Y receptor type 1target
Peptide YY (1-36)Neprilysinenzyme
Peptide YY (1-36)Neuropeptide Y receptor type 4target
Peptide YY (3-36)Neuropeptide Y receptor type 1target
Peptide YY (3-36)Neuropeptide Y receptor type 4target
Peptide YY (3-36)Neuropeptide Y receptor type 5target
Peptide YY (3-36)Neuropeptide Y receptor type 2target
Peptide-TC-C chemokine receptor type 5target
Peptide-TT-cell surface glycoprotein CD4target
PexelizumabComplement C5target
PhosphoramidonKell blood group glycoproteintarget
PhosphoramidonNeprilysintarget
PL-3994Atrial natriuretic peptide receptor 1target
PlecanatideGuanylyl cyclase Ctarget
PlitidepsinCytochrome P450 3A4enzyme
PlitidepsinCytochrome P450 2A6enzyme
PlitidepsinCytochrome P450 2E1enzyme
PlitidepsinCytochrome P450 4A11enzyme
PlitidepsinElongation factor 1-alpha 2target
PlitidepsinPalmitoyl-protein thioesterase 1target
PM02734Serine/threonine-protein kinase mTORtarget
PM02734RAC-alpha serine/threonine-protein kinasetarget
PMX-205C5a anaphylatoxin chemotactic receptor 1target
PolaprezincSuperoxide dismutase [Mn], mitochondrialenzyme
PolaprezincGlutathione S-transferase theta-1enzyme
PolaprezincGlutathione peroxidase 1enzyme
PolaprezincPeroxiredoxin-1enzyme
PolaprezincPeroxiredoxin-5, mitochondrialenzyme
PolaprezincVascular endothelial growth factor receptor 1target
PolaprezincBeta-nerve growth factortarget
PolaprezincPlatelet-derived growth factor receptor betatarget
PolaprezincHeat shock protein HSP 90-alphatarget
PolaprezincHeat shock protein HSP 90-betatarget
PolaprezincHeme oxygenase 1enzyme
PolaprezincSuperoxide dismutase [Cu-Zn]enzyme
PolaprezincInterleukin-3target
PolaprezincInterleukin-6target
PolaprezincTumor necrosis factortarget
PolygelineFibronectintarget
Polymyxin BBacterial outer membranetarget
Polymyxin BSolute carrier family 15 member 2transporter
Polymyxin BDihydropteroate synthasetarget
PosatirelinThyrotropin-releasing hormone receptortarget
PR-15Collagen alpha-1(I) chaintarget
PR-15Collagen alpha-2(I) chaintarget
PR-15Collagen alpha-1(III) chaintarget
PralmorelinGrowth hormone secretagogue receptor type 1target
Pralmorelin6-phosphogluconate dehydrogenase, decarboxylatingtarget
PramlintideReceptor activity-modifying protein 3target
PramlintideReceptor activity-modifying protein 1target
PramlintideReceptor activity-modifying protein 2target
PramlintideGlucagon-like peptide 1 receptortarget
PramlintideCalcitonin receptortarget
PrezatideType-1 angiotensin II receptortarget
PRO-542Free fatty acid receptor 4target
ProtirelinThyrotropin-releasing hormone receptortarget
QuinupristinCytochrome P450 3A4enzyme
QuinupristinLarge ribosomal subunit protein uL22target
QuinupristinLarge ribosomal subunit protein uL10target
Quinupristin23S ribosomal RNAtarget
RamoplaninUDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferasetarget
RamorelixGonadotropin-releasing hormone receptortarget
RapastinelNMDA receptortarget
Recombinant CD40-ligandTumor necrosis factor receptor superfamily member 5target
Recombinant human plasma gelsolinAmyloid-beta precursor proteintarget
RegramostimGranulocyte-macrophage colony-stimulating factor receptor subunit alphatarget
RegramostimGM-CSF receptor alpha subunittarget
RegramostimCholinesteraseenzyme
RegramostimGranulocyte colony-stimulating factor receptortarget
RelamorelinGrowth hormone secretagogue receptor type 1target
RencofilstatPeptidyl-prolyl cis-trans isomerase F, mitochondrialtarget
RencofilstatPeptidyl-prolyl cis-trans isomerase Gtarget
RencofilstatPeptidyl-prolyl cis-trans isomerase Atarget
RencofilstatPeptidyl-prolyl cis-trans isomerase Btarget
Revakinagene taroretcelCiliary neurotrophic factor receptor subunit alphatarget
Reversin 121ATP-dependent translocase ABCB1target
Rezafungin1,3-beta-glucan synthase component FKS1target
Rezafungin1,3-beta-glucan synthase component GSC2target
RomidepsinCytochrome P450 3A5enzyme
RomidepsinCytochrome P450 3A4enzyme
RomidepsinATP-dependent translocase ABCB1transporter
RomidepsinSolute carrier family 22 member 2transporter
RomidepsinSolute carrier organic anion transporter family member 1B3transporter
RomidepsinCytochrome P450 1A1enzyme
RomidepsinCytochrome P450 2B6enzyme
RomidepsinCytochrome P450 2C19enzyme
RomidepsinHistone deacetylase 1target
RomidepsinHistone deacetylase 2target
RomidepsinHistone deacetylase 4target
RomidepsinProtein deacetylase HDAC6target
RomidepsinBile salt export pumptransporter
RomidepsinHistone deacetylasetarget
RomidepsinSolute carrier family 22 member 6transporter
RomidepsinSolute carrier organic anion transporter family member 1B1transporter
RomiplostimPlatelet-derived growth factor receptor alphatarget
RomiplostimFibroblast growth factor receptor 1target
RomiplostimPlatelet-derived growth factor receptor betatarget
RomiplostimThrombopoietin receptortarget
RomiplostimMast/stem cell growth factor receptor Kittarget
RomiplostimVascular endothelial growth factor receptor 2target
RomiplostimVascular endothelial growth factor receptor 1target
RomiplostimProto-oncogene tyrosine-protein kinase receptor Rettarget
RomiplostimAryl hydrocarbon receptortarget
Ropeginterferon alfa-2bCytochrome P450 1A2enzyme
Ropeginterferon alfa-2bCytochrome P450 2D6enzyme
Ropeginterferon alfa-2bCytochrome P450 2A6enzyme
Ropeginterferon alfa-2bInterferon alpha/beta receptor (IFNAR)target
RopocamptideN-formyl peptide receptor 2target
RopocamptideMas-related G protein-coupled receptor member X2target
RopocamptideP2X purinoceptor 7target
RopocamptideToll-like receptor 9target
RopocamptideInterferon-inducible protein AIM2target
RopocamptideToll-like receptor 2target
RotigaptideReplicase polyprotein 1abtarget
RotigaptideGap junction alpha-1 proteintarget
Rusalatide acetateIntegrin alpha-Vtarget
Rusalatide acetateIntegrin beta-3target
RWJ-800088Thrombopoietin receptortarget
S-(2,4-dinitrophenyl)glutathioneGlutathione S-transferase Mu 1target
S-(2,4-dinitrophenyl)glutathioneGlutathione S-transferase Mu 2target
S-(4-nitrobenzyl)glutathioneGlutathione S-transferase Ptarget
S-(N-hydroxy-N-bromophenylcarbamoyl)glutathioneHydroxyacylglutathione hydrolase, mitochondrialtarget
S-benzylglutathioneLactoylglutathione lyasetarget
S-benzylglutathioneGlutathione S-transferase A1target
S-benzylglutathioneGlutathione S-transferase A1enzyme
S-HexylglutathioneGlutathione S-transferase A1target
S-HexylglutathioneLactoylglutathione lyasetarget
S-HexylglutathioneGlutathione S-transferase Mu 4target
S-HexylglutathioneGlutathione S-transferase Ptarget
S-HexylglutathioneGlutathione S-transferasetarget
S-HexylglutathioneHematopoietic prostaglandin D synthasetarget
S-HexylglutathioneGlutathione S-transferase A1enzyme
S-HexylglutathioneGlutathione S-transferase theta-2target
S-Methyl glutathioneGlutathione S-transferase Mu 2target
S-NitrosoglutathioneV-ATPase Subunitstarget
S-NitrosoglutathioneThioredoxinenzyme
S-NitrosoglutathioneGlutathione reductase, mitochondrialenzyme
S-NitrosoglutathioneGlutathione hydrolase 1 proenzymeenzyme
S-NitrosoglutathioneAlcohol dehydrogenase class-3enzyme
S-NitrosoglutathioneThioredoxin reductase 1, cytoplasmicenzyme
S-octylglutathioneGlutathione S-transferase Mu 4target
Salmon calcitoninCalcitonin receptortarget
Sar9, Met (O2)11-Substance PSubstance-P receptortarget
Sar9, Met (O2)11-Substance PProstaglandin G/H synthase 2enzyme
Sar9, Met (O2)11-Substance PCholinesteraseenzyme
Sar9, Met (O2)11-Substance PAromataseenzyme
SaralasinType-2 angiotensin II receptortarget
SaralasinType-1 angiotensin II receptortarget
SargramostimGranulocyte-macrophage colony-stimulating factor receptor subunit alphatarget
SargramostimInterleukin-3 receptor subunit alphatarget
SargramostimCytokine receptor common subunit betatarget
SargramostimSyndecan-2target
SaxagliptinCytochrome P450 3A5enzyme
SaxagliptinDipeptidyl peptidase 4target
SaxagliptinCytochrome P450 3A4enzyme
SaxagliptinOrganic anion transporter 3transporter
SaxagliptinMultidrug resistance-associated protein 1transporter
SaxagliptinSolute carrier organic anion transporter family member 4C1transporter
SCY-635Peptidyl-prolyl cis-trans isomerase Atarget
SCY-635Guided entry of tail-anchored proteins factor CAMLGtarget
Secretin humanSecretin receptortarget
Secretin humanSecretintarget
SelepressinVasopressin V1a receptortarget
SemaglutideNeprilysinenzyme
SemaglutideDipeptidyl peptidase 4enzyme
SemaglutideAlbumincarrier
SemaglutideGlucagon-like peptide 1 receptortarget
SemaglutideLipoprotein lipaseenzyme
SemparatideParathyroid hormone 2 receptortarget
SER-100Nociceptin receptortarget
SermorelinGrowth hormone-releasing hormone receptortarget
SetmelanotideMelanocortin receptor 4target
SF1126Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoformtarget
SF1126Serine/threonine-protein kinase mTORtarget
SF1126DNA-dependent protein kinase catalytic subunittarget
SF1126Phosphatidylinositol 3-kinase regulatory subunit gammatarget
SF1126Phosphatidylinositol 3-kinase regulatory subunit betatarget
SF1126Phosphatidylinositol 3-kinase regulatory subunit alphatarget
SincalideCholecystokinin receptor type Atarget
SincalideGastrin/cholecystokinin type B receptortarget
SincalideSolute carrier organic anion transporter family member 1B3transporter
Skf 107457Gag-Pol polyproteintarget
SoblidotinTubulintarget
SolnatideEpithelial sodium channel subunit deltatarget
SolnatideEpithelial sodium channel subunit alphatarget
SomapacitanGrowth hormone receptortarget
Somapacitan11-beta-hydroxysteroid dehydrogenase 1enzyme
SomapacitanCytochrome P450 2C12, female-specificenzyme
SomapacitanCytochrome P450 1A2enzyme
SomapacitanCytochrome P450 2C19enzyme
SomapacitanAlbumincarrier
SomatorelinGrowth hormone-releasing hormone receptortarget
SomatostatinSomatostatin receptor type 1target
SomatostatinSomatostatin receptor type 2target
SomatostatinSomatostatin receptor type 3target
SomatostatinSomatostatin receptor type 4target
SomatostatinSomatostatin receptor type 5target
SomatostatinATP-dependent translocase ABCB1transporter
SomatostatinMu-type opioid receptortarget
SomatostatinDelta-type opioid receptortarget
SomatostatinSomatostatin receptortarget
SomatostatinCytochrome P450 3A4enzyme
SomatotropinATP-dependent translocase ABCB1transporter
SomatotropinCytochrome P450 2C19enzyme
SomatotropinCytochrome P450 1A2enzyme
SomatotropinProlactin receptortarget
SomatotropinGrowth hormone receptortarget
SomatremInsulin-like growth factor 1 receptortarget
SomatremGrowth hormone receptortarget
SomatrogonGrowth hormone receptortarget
Somatropin pegolGrowth hormone receptortarget
SonelokimabInterleukin-17Atarget
SonelokimabInterleukin-17Ftarget
SovateltideEndothelin receptor type Btarget
SpiraprilSolute carrier family 15 member 2transporter
SpiraprilSolute carrier family 15 member 1transporter
SpiraprilAngiotensin-converting enzymetarget
ST-003Galanin receptor type 2target
ST-003Galanin receptor type 1target
StallimycinTATA-box-binding proteintarget
StallimycinNucleolar transcription factor 1target
StallimycinAdenine DNA glycosylasetarget
StallimycinBifunctional 3'-5' exonuclease/ATP-dependent helicase WRNtarget
StallimycinRecQ-like DNA helicase BLMtarget
StallimycinProtein S100-Btarget
StallimycinHigh mobility group protein HMG-I/HMG-Ytarget
Substance PSubstance-P receptortarget
TabimorelinCytochrome P450 3A4target
TabimorelinGrowth hormone secretagogue receptor type 1target
TAK-448Metastasis-suppressor KiSS-1target
TalabostatDipeptidyl peptidase 9target
TalabostatDipeptidyl peptidase 8target
TalabostatProlyl endopeptidase FAPtarget
TallimustineC-X-C chemokine receptor type 2target
TallimustineDNAtarget
TaltirelinThyrotropin-releasing hormone receptortarget
TaltobulinATP-dependent translocase ABCB1transporter
TaltobulinTubulintarget
TasidotinProlyl endopeptidasetarget
Technetium Tc-99m maraciclatideIntegrin alpha-Vtarget
Technetium Tc-99m maraciclatideIntegrin beta-3target
Technetium Tc-99m maraciclatideIntegrin beta-5target
TeicoplaninD-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycantarget
TelaprevirCytochrome P450 3A4enzyme
TelaprevirGenome polyproteintarget
TelaprevirATP-dependent translocase ABCB1transporter
TelaprevirAlbumincarrier
TelaprevirAlpha-1-acid glycoprotein 1carrier
TelaprevirSolute carrier organic anion transporter family member 1B1target
TelaprevirSolute carrier organic anion transporter family member 2B1target
TelaprevirGenome polyproteintarget
TelavancinPeptidoglycan precursorstarget
TelavancinCorticotropin-releasing hormone receptor 1target
TelavancinNeuronal acetylcholine receptor subunit alpha-3target
TelavancinNeuronal acetylcholine receptor subunit alpha-2target
TengonerminAminopeptidase Ntarget
TeriparatideParathyroid hormonetarget
TeriparatideParathyroid hormone/parathyroid hormone-related peptide receptortarget
TerlakirenRenintarget
TerlipressinVasopressin V1b receptortarget
TerlipressinVasopressin V2 receptortarget
TerlipressinVasopressin V1a receptortarget
TesamorelinGrowth hormone-releasing hormone receptortarget
TetracosactideAdrenocorticotropic hormone receptortarget
TeverelixGonadotropin-releasing hormone receptortarget
ThiostreptonProteasome subunit beta type-3target
THR-184Bone morphogenetic protein receptor type-1Atarget
ThrombopoietinThrombopoietin receptortarget
ThymalfasinAngiotensin-converting enzymetarget
ThymalfasinToll-like receptor 9target
ThyrotropinThyrotropin receptortarget
TifuvirtidePlasma serine protease inhibitortarget
TigapotideSmall ribosomal subunit protein uS2target
TigapotideBeta-microseminoproteintarget
TiplimotideMyelin basic proteintarget
TirzepatideGlucagon-like peptide 1 receptortarget
TirzepatideAlbumincarrier
TirzepatideGastric inhibitory polypeptide receptortarget
Tisotumab vedotinATP-dependent translocase ABCB1transporter
Tisotumab vedotinTissue factortarget
Tisotumab vedotinCytochrome P450 3A4enzyme
TP-3654Broad substrate specificity ATP-binding cassette transporter ABCG2transporter
TP-3654Serine/threonine-protein kinase pim-3target
TP-3654Serine/threonine-protein kinase pim-2target
TP-3654Serine/threonine-protein kinase pim-1target
TraferminFibroblast growth factor receptor 2target
Tralesinidase alfaCation-independent mannose-6-phosphate receptortarget
Tralesinidase alfaHeparan sulfatetarget
TriptorelinGonadotropin-releasing hormone receptortarget
TrofinetideSolute carrier organic anion transporter family member 1B3transporter
TrofinetideSolute carrier organic anion transporter family member 1B1transporter
TrofinetideUDP-glucuronosyltransferase 2B15enzyme
TrofinetideUDP-glucuronosyltransferase 2B7enzyme
TrofinetideUDP-glucuronosyltransferase 1A9enzyme
TrofinetideCytochrome P450 3A4enzyme
TRV-120027Type-1 angiotensin II receptortarget
TrypanothioneTrypanothione reductasetarget
TT-232Pyruvate kinase PKMtarget
Tucotuzumab celmoleukinEpithelial cell adhesion moleculetarget
TyrothricinPhospholipid membranetarget
TyrothricinBeta-galactosidasetarget
TyrothricinAcetylcholinesterasetarget
UlaritideAtrial natriuretic peptide receptor 1target
Urocortin-2Corticotropin-releasing hormone receptor 2target
UrofollitropinFollicle-stimulating hormone receptortarget
ValinomycinBile salt export pumptransporter
ValinomycinSodium/Potassium Transporting ATPasetarget
ValinomycinATP-dependent translocase ABCB1transporter
ValspodarSolute carrier organic anion transporter family member 1B1transporter
ValspodarSolute carrier organic anion transporter family member 1B3transporter
ValspodarATP-dependent translocase ABCB1transporter
ValspodarCoagulation factor Xtarget
ValspodarATP-dependent translocase ABCB1target
VancomycinD-Ala-D-Ala moiety of NAM/NAG peptide subunits of peptidoglycantarget
VancomycinAlbumincarrier
Vancomycinalpha1-acid glycoproteincarrier
VancomycinHistamine H1 receptorcarrier
VapreotideCytochrome P450 3A4enzyme
VapreotideSomatostatin receptor type 3target
VapreotideSomatostatin receptor type 2target
VapreotideSubstance-P receptortarget
VapreotideSomatostatin receptor type 5target
Vasoactive intestinal peptideAlpha adrenergic receptortarget
Vasoactive intestinal peptideVasoactive intestinal polypeptide receptor 1target
VasomeraVasoactive intestinal polypeptide receptor 1target
VasomeraVasoactive intestinal polypeptide receptor 2target
VasopressinATP-binding cassette sub-family C member 2transporter
VasopressinVasopressin V1b receptortarget
VasopressinVasopressin V2 receptortarget
VasopressinVasopressin V1a receptortarget
VasopressinOxytocin receptortarget
VEGFR2-169MHC class I HLA-A proteintarget
VeldoreotideSomatostatin receptor type 2target
VeldoreotideSomatostatin receptor type 4target
VeldoreotideSomatostatin receptor type 5target
Viomycin16S/23S rRNA (cytidine-2'-O)-methyltransferase TlyAtarget
Vipivotide tetraxetanGlutamate carboxypeptidase 2target
ViquidacinDNA gyrase subunit Atarget
ViquidacinDNA gyrase subunit Btarget
Viral Macrophage-Inflammatory ProteinC-X-C chemokine receptor type 4target
Viral Macrophage-Inflammatory ProteinC-C chemokine receptor type 8target
Viral Macrophage-Inflammatory ProteinC-C chemokine receptor type 2target
Viral Macrophage-Inflammatory ProteinC-C chemokine receptor type 5target
Virginiamycin M1Streptogramin A acetyltransferasetarget
Virginiamycin S1Large ribosomal subunit protein eL37target
VM4-037Carbonic anhydrase 9target
VM4-037Carbonic anhydrase 12target
VobarilizumabInterleukin-6 receptor subunit alphatarget
VoclosporinCalcineurin subunit B type 1target
VoclosporinCalcineurin subunit B type 2target
VoclosporinATP-dependent translocase ABCB1transporter
VoclosporinCytochrome P450 3A4enzyme
VoclosporinGuided entry of tail-anchored proteins factor CAMLGtarget
VoclosporinProtein phosphatase 3 catalytic subunit alphatarget
VosoritideAtrial natriuretic peptide receptor 2target
XempritolimodToll-like receptor 5target
XPro1595Tumor necrosis factortarget
Z-Pro-ProlinalProlyl endopeptidasetarget
Z-Pro-Prolinalprolyl oligopeptidasetarget
ZilucoplanComplement C5target
ZilucoplanCytochrome P450 4F2enzyme
Zoptarelin doxorubicinGonadotropin-releasing hormone receptortarget